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ABSTRACT

MHC (B) COMPLEX RECOMBINANT IMMUNE RESPONSE

By

Nicole G. Wilkinson
University of New Hampshire, December, 2006

Recombination between chicken major histocompatibility complex (MHC)
class I B-F and class IV B-G genes has enabled more precise identification of
genes controlling immune responses. Congenic lines, each containing a unique
MHC recombinant, were developed with 99.9% genetic uniformity to inbred Line
UCD 003 (B17B17). A new recombinant, R13 (BF17-BG23), originated in the
tenth backcross generation for R1 (BF24-BG23). Two experiments tested the
R13 immune response to bovine red blood cells (BRBC) and Rous sarcoma virus
(RSV).
A single R13B17 sire mated to five R13B17 dams produced progeny
segregating for R13R13, R13B17, and B17B17 genotypes. These progeny were
injected with 1 mL of 2.5% bovine RBC (BRBC) at 4 and 11 weeks of age to
stimulate primary and secondary immune responses, respectively.
ix
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Serum

antibody titers against BRBC seven days post-injection were evaluated by least
squares ANOVA. Primary total and mercaptoethanol (ME)-resistant antibodies
were significantly lower in R13R13 chickens compared with R13B17 and B17B17
genotypes. R13R13 chickens also had significantly lower secondary total and
ME-resistant antibodies than did the R13B17 genotype. The results suggest that
genetic differences in R13 homozygotes lower their antibody response to BRBC.
This lower response is mitigated by a complementary effect in R13B17
heterozygotes.
Congenic lines homozygous for MHC recombinants (R1R1 = BF24-BG23,
R2R2 = BF2-BG23, R4R4 = BF2-BG23, R5R5 = BF21-BG19, R13R13 = BF17BG23), were inoculated with 20 pock forming units of RSV subgroup C at six
weeks of age. Tumor size was scored six times over ten weeks post-inoculation
followed by assignment of a tumor profile index (TPI). Tumor growth over time
and rank transformed TPI values were analyzed by least squares ANOVA.
Tumor size increased over the experimental period in all genotypes except
R5R5. R5R5 chickens had significantly lower TPI values compared with R2R2,
i
R4R4 and R13R13 chickens. R1R1 did not differ significantly from any of the
other genotypes.

The R5 BF21 produced a greater response against RSV

tumors than did BF24, BF2 and BF17. Together, the results indicate that the
R13 recombination event impacted genes that lowered antibody responses and
possibly the antitumor response.

x
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CHAPTER I

LITERATURE REVIEW

Introduction
From the smallest to the largest organism, survival is dependent on the
ability of that organism to defend itself against foreign invasion. The immune
system is chiefly responsible for this defense. This system can be broken down
into two major parts; adaptive immunity, and innate immunity. Innate immunity is
present from birth, while the adaptive immune system is acquired through
exposure to foreign invaders (antigens).

The key to the immune system is

self/non-self recognition. Genes of the major histocompatibility complex (MHC)
code for cell surface proteins that mark cells as self or non-self; infected or non
infected. These MHC molecules are the fundamental basis for initiation of the
immune response.
The Major Histocompatibility Complex
History of the MHC
In the early 1900’s, studies burgeoned that sought to understand the
immune response to disease.

Those studies would become focused on the

1
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mechanisms

responsible for self/non-self recognition,

eventually

leading

researchers to the discovery and investigation of the MHG.
In 1930, Todd injected blood from one chicken into another, a technique
known as iso-immunization.

When these iso-immunizations were preformed

except with close relatives, the recipient chicken produced iso-agglutinations
against cells of the donor (Todd, 1930).

Therefore, the host for the iso

immunization was able to identify blood cells from another domestic fowl as
being foreign.

With the exception of those domestic fowl that were closely

related, the foreign erythrocytes were treated as antigenic, eliciting an immune
response. Iso-agglutination did not occur with at least one of the domestic fowl’s
parents, indicating an inherited link. This discovery provided evidence for what
we now know to be a genetically inherited trait (Todd, 1931).
The Humoral Theory of Transplant Rejection
From 1909 to 1914, Clarence Cook Little laid the ground work for the
genetic basis of transplant rejection.

Little was interested in the genes

responsible for cancer resistance, but observations made in his experiment were
formulated by George Snell in 1948 into the laws of transplant rejection (Snell,
1948). Little did several experiments with inbred cate. Perhaps his most famous
project, published in Science in 1914, described the Mendelian genetics involved
in the inheritance of coat color in cats (Little, 1914). After 1914, however, Little’s
experiments focused on the rejection of tumors transplanted between inbred
mice (Little, 1915a; Little, 1915b; Little, 1920; Little and Johnson, 1922; Little and

2
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Tyzzer, 1916).

His major observations from these experiments, which were

eventually turned into laws by Snell, are as follows:

“(1) Strain A transplants to strain A recipients succeed; (2) strain A
transplants to strain B recipients fail (and vice versa); (3) Strain A
(or B) transplants to (AxB) F1 recipient succeed; (4) (AxB) F1
transplants to strain A (or B) fail; (5) Strain A (or B) transplants to
members of an F2 generation almost always fail, but occasionally
succeed.” (Snell, 1948)

In the 1930’s, two scientists in different parts of the world were working on
the same project without knowledge of the others’ work. The two scientists were
Peter Gorer, a medical doctor/ immunologist at Guys Hospital of London, and
George Snell, a geneticist from The Jackson Lab of Bar Harbor, Maine. Their
eventual collaboration led to the discovery of the mouse histocompatibility
system (H-2).
Peter Gorer’s research focused solely on the serologipal characterization
of the H2 antigens. He was investigating the possible link between blood group
antigens and allogenic tumor transplant rejection (Gorer, 1938).

Gorer first

identified the four blood groups of the mouse: I, II, III, and IV. He used antisera
to detect the presence of Antigen II in the mice. When these mice were later
injected with tumors from mice that had tested positive for the presence of
Antigen II, the injected mice died from tumor injection.

Gorer theorized that

Antigen II, which was present on all nucleated cells, was responsible for self/
non-self recognition.

Gorer noted that the blood types segregated with

susceptibility and resistance to a transplantable tumor (Gorer, 1937).

3
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George Snell at the Jackson lab, was inspired by a review, which he
edited, on the genetics of tumor transplantation written by the founder of the
Jackson Lab, Clarence C. Little (Little, 1941).

In 1944, Snell suspected a

particular locus, named the Histocompatibility or H locus, was responsible for
transplanted tumor rejection in the mouse.
In formulating a plan to determine if the H locus was truly responsible for
self/ non-self recognition Snell formulated a plan that would allow him to study
the effects of the H locus alone. To do this Snell developed the first congenic
strain of mice. Snell crossed mice possessing a tumor resistant gene with mice
from an inbred line. He then selected for the tumor resistant gene and back
crossed those mice to the parental inbred line for ten generations. After ten
generations the background DNA of the tumor resistant congenic line would be
99.9% the same as the inbred line, and the only difference between congenic
lines was the H locus (Snell, 1948).

Certain congenic mouse strains yielded

j

■

accelerated tissue graft rejection depending on the type of H locus. The strain
that was resistant to transplantable tumors became known as CR (congenic
resistant) [Gorer et al., 1948]. By using selected markers for the H locus, Snell
was able to isolate a single H locus responsible for tumor rejection. One of these
markers was the fused (fu) mutation which was phenotypically expressed as the
fusion of the tail vertebrate leading to deformation of the tail. Snell found that the
single H locus responsible for tumor growth and the fu locus were genetically
linked (Gorer etal., 1948).

4

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

In 1946, Little met Gorer at a conference in Italy and brought him back to
the Jackson Lab to work with Snell, a collaboration that resulted in the first
identification of the mouse MHC (Klein, 2001). The two designed an experiment
to determine if Snell’s fu-linked H locus was the same locus that coded for
Gorer’s Antigen II. Gorer tested the fused mutation mice for Antigen II before
tumor inoculation. Through this experiment they realized that they had indeed
been working on the same locus. Together they named the locus H-2, H for
Histocompatibility system and 2 for Antigen II (Gorer et a!., 1948; Klein, 2001;
Snell, 1948).
The Cellular Theory of Transplant Rejection
In 1942, Gibson and Medawar reported on “The fate of skin homografts in
man”. Through observations of burn patients made in a clinical setting Gibson
and Medawar (1942) reported that patients, treated with skin grafts, rejected
second homographs from the same donor quicker than the first homograph. A
year later with the need for badly burned children to be treated due to bombing in
London as a result of World War II, the British government funded Medawar to
begin animal experiments using skin autografts in hopes of developing an
understanding of the factors involved in transplant rejection (Acierno, 1994).
Gibson and Medawar used skin allografts (grafts from the same species) and
skin autografts (grafts from the same subject) in transplantation experiments
using rabbits. Grafting skins between rabbits caused the development of cellular
filtrate destroying the graft within 7-10 days (Gibson and Medawar, 1942). Upon
secondary introduction of an allograft to the same rabbit, graft rejection
5
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happened more rapidly than in the first introduction (Gibson and Medawar,
1942). Therefore, the rabbit must possess a mechanism that distinguishes self
cells from non-self cells and can initiate a rejection response against the non-self
cells.

From here it was hypothesized that secondary exposure to the same

antigen causes a faster rejection response (Gibson and Medawar, 1942). This
second response became known as the secondary rejection or second set
response.
The Chicken (Gallus Gallus Domesticus) MHC (The B Complex)
The first discovery of cellular antigen was in the chicken by Briles and
McGibbon in 1948 (Briles and McGibbon, 1948). In 1950, Briles found that the
chicken had two highly polymorphic red blood cell antigens, A and B (Briles et al.,
1950). Briles also noted that these two antigens were inherited independently
(Briles etal., 1950).
In experiments by Schierman and Nordskog where skin grafts were
transplanted onto birds that possessed the same B genotype and different B
genotype, the birds with the same B genotype accepted the skin graft while birds
with different B genotypes rejected the skin graft (Schierman and Nordskog,
1961). These results indicated that the B locus was not only responsible for red
cell antigens but was also responsible for self/non-self recognition in the chicken.
Therefore, the MHC of the chicken was named the B complex (Schierman and
Nordskog, 1961).
Ornithologists Jaffe and McDermid found a relationship between the B
blood type, discovered by Briles, and self/non-self recognition. This relationship
6
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was parallel to that found in earlier studies by Gorer and Snell that defined the
relationship between mouse blood types and self/non-self. In 1962, Jaffe and
McDermid took blood from lines of adult hens with three different B genotypes,
B19B19, B21B21, and B19B21. Each of these donors contributed to a 0.1 ml
portion of blood that was intravenously injected into different fifteen day old
chicks. Each chick blood type (B21B21, B19B21, or B19B19) was paired with
each donor blood type and the results were compared. To quantify the graft host
reaction, the spleens of the chicks were removed after four days and weighed to
determine the presence or absence of splenomegaly. The nine groups of paired
host /recipient chickens were compared with three control groups that were
grouped by chick genotype. When the host and the recipient had different B
locus genotypes, i.e. when B21B21 was host or recipient for blood from or to
B19B19, splenomegaly occurred. When blood from a host with the same B locus
complex as the recipient was used, splengomegaly did not occur. When either
the host or recipient had the heterozygous B locus genotype (B19B21)
splenomegaly did not occur. These experiments demonstrated that the B locus
was chiefly responsible for control of the graft versus host reaction. Because
there was some slight enlargement seen in groups where none would be
expected, there are other antigens produced by non self blood that may play a
small roll in self-nonself recognition (Jaffe and McDermid, 1962).
When using the same lines, studies by Cole in 1968 exposed strong
associations between these MHC haplotypes and resistance to Marek’s disease.
Cole reported that the B21B21 haplotype made individuals 95% resistant to the

7
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disease while individual chickens with a MHC haplotype of B19B19 suffered an
100% mortality rate when exposed to Marek’s disease (Cole, 1968).
Chromosomal Composition of Chromosome 16
The chicken MHC is located on Chromosorrie 16 (Figure 2) and contains
tightly linked polymorphic regions (Bloom and Bacon, 1985). Construction of
chromosome 16 consists of two main loci which play major roles in controlling
MHC immunity, these loci are B and Y (Briles et al., 1993). The Y locus was
originally known as Rfip-Y (restriction fragment polymorphism-Y), but is now
known as MHC-Y. MHC-Y is physically separated for the B locus by the NOR
region on chromosome 16. The NOR is a region of high recombination which
makes the two loci appear to be on different chromosomes. This separation
allows for the two loci to be inherited independently (Briles et al., 1993; Miller et
al., 1994a; Miller et al., 1996).
In 1988, the first molecular map of the chicken MHC was published by
Guillemont and colleagues. This map located class I, class II and additional
linked loci in four cosmid contigs: CC1, CC2, CC3, and CC4 (Guillemot et al.,
1989b).

CC2, CC3, and CC4 were mapped to the Y (Rfp-Y) region of

chromosome 16 while CC1 was mapped to the B system (Briles et al., 1993;
Guillemot et al., 1989a; Guillemot et al., 1988; Guillemot et al., 1989b; Kaufman
et al., 1999b; Kaufman et al., 1995).

8
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Figure 1. Chromosome 16 of the chicken. The B system, Y system, and NOR
major regions.
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B Complex

,

All vertebrate species studied so far have a MHC (Nordskog et al., 1987).
In 1999, two profound genetic studies were done on MHC complexes that
revealed the vertebrate MHC to be a complex multigene family. The sequencing
of the human leukocyte antigen (HLA) [Beck, 1999] and the B complex in the
chicken (Kaufman, 1999) became the foundation for research that established
loci found in the MHC as coding for receptors on the surfaces of certain immune
and non immune cells. These particular receptors were found to bind antigenic
peptides to stimulate immune responses. The MHC molecules were therefore
defined as essential mediators in both adaptive and acquired immune responses
in all vertebrate species (Trowsdale, 1995). Structural and functional similarities
such as interactions between antigen presenting cells (i.e. T cells and B cells)
when generating an antibody response are regulated by the B complex in a
manner comparable to the MHC of other species (Vainio et al., 1987).
In

1964,

Zuckerkandl

and

Pauling

conducted

experiments

that

demonstrated the advantages of heterozygosity, sexual reproduction, and
outbreeding in resistance to disease.

Zuckerkandl and Pauling found that

genetic diversity at the MHC loci increased resistance to infectious, pathogens
(Clarke and O'Donald, 1964; Zuckerkandl and Pauling, 1965). The chicken MHC
is polymorphic for class I, class II, and class IV molecules (Longenecker and
Mosmann, 1981).

It is this polymorphism that creates diversity in MHC

molecules between individuals of the same species (Moller et al., 1991). These
10
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genetic variations yield differences between immune responses to varying
antigens depending upon MHC haplotype (Lamont, 1991).
There is great disparity between the different B complexes in both immune
response and disease outcome. This is due to the B complex’s determination of
several sets of essential immunological functions in response to infection. A B
haplotype is comprised of three sub-regions: B-F, B-L, and B-G. For example:
all B5 chickens have F5, L5, and G5 genes, and therefore the corresponding F5,
L5, and G5 surface antigens (Briles et al., 1982). Recombination between the
B-F and the B-L region occurs so infrequently that the two regions are often
considered one and referred to as the B-F/B-L region. This region is located by
the telomeric end of chromosome 16 (Guillemot et al., 1988).

However, one

exception that has been found in an inbred line from Prague CB is the B
genotype B12B12. The B-L antigens from this line and the B19 haplotypes are
the same while the B-F and B-G alleles are clearly different.
The MHC haplotype specifically controls the affinity for a MHC molecule to
bind to an antigenic peptide by determining the antigen-binding region of the
MHC molecule. Since T-cells can only bind to antigenic peptide bound to a MHC
molecule on the surface of an antigen presenting cell (APC), the ability of MHC
molecules to bind and present antigen controls the adaptive immune response.
The Human, the Mouse, and the Chicken
There are three types of molecules that identify pathogen: MHC Class I,
MHC class II, and complement proteins.

These molecules all play a role in

identifying foreign antigen and presenting it to the cells of the immune system for
11
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destruction. MHC class I molecules are found on the surface of all nucleated
cells. They bind to endogenously processed viral peptide in the endoplasmic
reticulum (ER) and bring it to the cell surface for recognition by CD8+ receptor.
Class I molecules are responsible for self non-self recognition.
MHC class II molecules are found on the surface of antigen presenting
cells (APC) such as macrophages, activated B-cells and dendritic cells (DC).
Class II molecules bind to antigenic peptide from endogenously processed
pathogens. Once bound, MHC class II molecules bring the peptide to the APC
surface for recognition by CD4+ receptor T-cells (Helper T-cells), a costimulator
for the activation of B cells. When activated the B-cell produces antigen specific
antibodies that can opsonize an invading pathogen (i.e. bacterium or virus)
tagging the pathogen for destruction by other cells. The MHC class II molecules
control regulatory infections among cells of the immune system.
Complement proteins surround pathogens such as bacteria, opsonizing
them for phagocytosis by phagocytes.

They are also capable of forming

membrane-attack complexes which are complement made pores in the cell
membrane of the pathogen that cause cell lysis.
There are four MHC classes of immunological genes for the chicken:
Class I, Class'll, Class III, and Class IV. The chicken B complex encodes genes
for Class I, Class II and Class IV molecules through B-F, B-L, and B-G genes
respectively. Although the chicken posses genes for class III molecules they
reside outside of the B complex and chromosome 16 (Hillier et al., 2004). Class I
and Class II genes of the B complex are homologous to those found in

12
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mammals. Class IV B-G genes are so far unique to the chicken and lie within the
B complex (Pink et al., 1977).
In humans, MHC is known as Human Leukocyte Antigen (HLA).

It is

located on chromosome six and is the most gene rich region of the human
genome. With 200 loci identified, an estimated 40% of the expressed genes in
this region have immune function.

In humans, class I genes reside near the

telomere, the class II by the centromere, and the class III separate the two (Beck,
1999). B complex MHC class I molecules are encoded in the B-F region of the B
complex for the chicken. Homologous genes are encoded by HLA-A, HLA-B,
and HLA-C genes on chromosome six of the human genome and H-2K, H-2, and
H-2L genes on chromosome 17 in the mouse (Gunther and Walter, 2001).
The B complex has been completely sequenced (Kaufman et al., 1999b).
This sequencing has revealed two class I (BF1 and BF2) and two class II (BLB1
and BLB2) loci found within a 92-kb region of the B complex (Kaufman et al.,
1999b; Kaufman et al., 1995).

Unlike the MHC’s of well studied mammalian

families with multiple class I and class II genes, the chicken MHC is simple with
only a few class I and class II genes with one of each being dominantly
expressed.

Based on low polymorphism, sequence divergence, expression

level, effect on disease resistance and lymphocyte reaction evidence indicates
that much the genome is not specifically associated with the class molecules but
instead codes for non-polymorphic molecules. Although biologically important
and part of the MHC these genes do not seem to have an immunological role

13
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(Juul-Madsen et al., 1997; Pharr et al., 1996; Vallejo et al., 1997; Zoorob et al.,
1993).
Kaufman proposed that the chicken MHC was simple when compared to
the mouse and human.

In the human, class I molecules HLS-A, HLA-B and

HLA-C are all multigene families with different peptide-binding specificities.
Humans that are MHC heterozygous have three different possibilities for the
appropriate peptide-binding interaction. Therefore, these individuals would have
three possible chances to present a peptide to a T-cell to elicit a T-cell response
(Kaufman and Salomonsen, 1997).
Restriction Fragment Polvmorphism-Y (Rfp-Y) System
In 1993, Southern blot hybridization detected a second cluster of MHC
genes not within the B complex in a family of fully pedigreed chickens over three
generations.

Briles named this region Restriction Fragment Polymorphism-Y

(Rfp-Y) which is now known as the MHC-Y system (Briles et al., 1993). CC2,
CC3, and CC4 have been mapped to the Y system (Briles etal., 1993; Fulton et
al., 1995; Miller et al., 1994b; Miller et al., 1996). The Y region contains two non
classical MHC class I a-chain (Y-F) genes (Afanassieff etal., 2001; Miller et al.,
1994a), three non-polymorphic class II (3-chain genes (Miller et al., 1994a;
Zoorob et al., 1993), two c-type lectin genes (Y-Lec 1 and Y-Lec 2) [Bernot et al.,
1994; Miller et al., 1994a], and is suspected to code for many other genes not yet
explored (Miller et al., 1994b). Also found in the Y system are CR1 elements.
There are approximately 30,000 CR1 elements found scattered throughout the
chicken genome (Chen et al., 1991). CR elements are repetitive, degenerate,
14
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retroviral elements (Burch et ai, 1993).

CR1 elements are usually found in

association with a gene, located near the coding region of that gene. Although
homologous CR1 elements have been located within the Y system little is known
about them and their function (Rogers et a i, 2003). CR1 elements are thought to
have some effect on the regulation of gene expression for those genes which
they are associated although this has yet to be proven (Burch et ai, 1993; Chen
etal., 1991).
The Y system is located on chromosome 16 along with the B complex, but
resides on the opposite side of the NOR from the B complex (Figure 1).
Haplotypes of Y assort independently from B complex haplotypes.

Some Y

haplotypes are more complex than others among different chicken lines
(Afanassieff et al., 2001).
The Y system plays a minor role on phenotypic MHC effects in
comparison to the B system, but it does play a significant role. The Cornell line N
is homozygous for B21 genotype. When this line was segregated by Y haplotype
it produced three groups: Y5, Y7, and Y8. Matings of line N were conducted to
produce progeny with mismatched B and Y genes for skin graft transplant
experiments. When skin grafts were transplanted between birds with matched B
and Y genotypes the skin grafts were accepted. When the Y genotypes were
matched but the B were not, the matched Y genotype skin graft transplants were
rejected more slowly than the mismatched. When the B genotype was the same,
but the Y genotypes were not matched, the mismatched Y genotype skin graft
transplants were rejected. All mismatched B genotypes rejected the skin grafts
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quicker than any of the Y mismatched genotypes. Although the Y locus affects
transplant success, the B complex has a more dramatic effect on transplant
outcome (Pharr et al., 1996).
In chicken lines selected for resistance to MD, Y haplotype frequencies
differed in resistant and susceptible lines.

Haplotpye Y5 is found at higher

frequency and Y8 at lower frequency in MD-resistant Cornell line N. Additionally
haplotype Y7 is found only in line N but not line P. In MD-susceptible Cornell line
P, Y8 is found at higher frequency and Y5 at lower frequency. The Y9 haplotype
is found exclusively in Line P and not in line N. (Pharr et ai, 1997).
Homozygous B2 chickens regress tumors when inoculated with RSV.
Homozygous B5 chickens progress tumors when inoculated with RSV (Taylor et
al., 1992b). Among six Y haplotypes (Y1.2Y1.2, Y1.2 Y1.1, Y1.1 Y1.1, Y1.2 Y6
Y1.1Y6, and Y6 Y6) in B2B5 chickens, Rous sarcoma tumor profile index (TPI)
increased in order of Y haplotype, respectively. When homozygous B2 chickens
from lines 63 and I 2 were crossed, the F2 population was homozygous for the B2
haplotype but had different Y types. When segregated by Y type and exposed to
MDV there was no difference in their immune response (Vallejo et al., 1997). In
another study, Y haplotype affected the response to MDV (Wakenell et al., 1996).
The Y genes appear to work in conjunction with the B complex to mediate
immune response. Although the exact mechanisms coded for by the Y genes
are unknown it appears as though this mechanism acts directly on viral
replication and/or tumor cells to influence disease outcome.
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Class Molecules
MHC Glycoprotein Molecules
MHC molecules are glycoproteins encoded in the large cluster of genes
known as the major histocompatibility complex (MHC). The B complex is the
chicken MHC. The B complex is composed of heterodimeric transmembrane
glycoproteins that act in presenting antigenic peptides to T-cells on the surface of
infected antigen presenting cells (Kroemer et a i, 1990; Plachy et al., 1992).
There are three classes of MHC molecules in the chicken; class I (B-F), class II
(B-L), and class IV (B-G) (Plachy et al., 1992).
MHC Class I Glycoprotein Structure
The chicken B-F genes code for class I molecules which are polypeptides.
Human HLA-A, HLA-B and HLA-C genes code for homologous molecules similar
in size, structure, and function (Ziegler and Pink, 1975). These molecules are
responsible for launching an immune response against endogenous antigen
(Bacon and Dieted, 1991).

The MHC class I molecule is a heterodimer,

membrane spanning molecule, composed of two proteins (Dessen et al., 1997).
The larger protein of the molecule is the a-chain protein weighing 44 Kd. The
a-chain protein is the membrane spanning portion approximately 350 amino
acids in length, 75 of which are at the carboxylic end comprising the
transmembrane and cytoplasmic portions. The remaining 270 amino acids are
divided into three globular domains: a-1, a-2 and a-3 prime. The a-1 domain is
closest to the amino terminus and a-3 closest to the membrane. The second

17

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

portion of the molecule is the small globular protein p2 microglobulin at a weight
of 12 Kd. The (B2 microglobulin associates primarily with the a-3 prime domain
and is necessary for MHC stability (Dessen et al., 1997).
Class I Surface Antigens
The chicken B-F molecules are found on the surface of all nucleated cells,
including chicken red blood cells. These molecules are homologous to the class
I molecules found in mammals and are responsible for immune response against
tumor cells or virally-infected cells (Bacon and Dietert, 1991). The MHC class I
molecule binds short peptides usually with a length of about 8-10 amino acids
(Bouvier and Wiley, 1994). These peptides are derived endogenously from a
viral or parasitic source. Immunogenic peptides for MHC class I molecules can
be derived from viral proteins (Riddell etal., 1991; Yewdell etal., 1988).
Class I molecules bind to and deliver antigenic peptide to the surface of
cells for presentation to CD8+ cytotoxic T cells (Th1). When peptide binds to the
peptide-binding cleft of the MHC class I molecule it stabilizes the structure of the
MHC class I molecule and therefore is called an anchor residue (Bouvier and
Wiley, 1994).
The Endogenous Route
The endogenous route begins when a virus’s surface proteins (ligands)
bind to a cell’s surface proteins (receptor). Once attached, the virion (portion of
the virus that contains the genome and essential polymerases) penetrates the
cell cytoplasm. Virus can penetrate the cells cytoplasma by one of three ways.
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1) The virus is translocated across the plasma membrane. 2) The virus fuses
it’s envelope with the cell membrane. 3) The virus uses the cell’s receptors to
employ receptor-mediated endocytosis and fusion with endosomal membranes.
The virus then enters the nucleus of the cell and uses viral enzymes, for
retroviruses like RSV this is reverse transcriptase, to generate DNA from their
RNA template. Newly synthesized viral genomes and capsid proteins are then
assembled into progeny virions.
released into the cytosol.

Viral proteins (endogenous antigens) are

Endogenous antigenic peptides are formed in the

cytosol by cytosolic proteasomes from their parent proteins and then transported
into the ER.

The proteasome is a large, cylindrical, multicatalytic protease

complex. It is comprised of four stacked rings each containing seven subunits. It
is a ubiquitin-dependent degradation pathway for cytosolic proteins (Uebel and
Tampe, 1999). The proteasome is stimulated by the cytokine Interferon gamma
(IFN-y) through proteasome regulatory complex (PA28).

PA28 is a seven

membered ring comprised of two protein molecules, PA28a and PA280. The
PA28 ring can bind to both or one of the ends of the immunoproteasome
increasing the rate at which peptides are released. This rate increase is due to
increased cleavage of polypeptides after hydrophobic residues, and reduced
cleavage after acidic residues. This cleavage produces protein peptides with
carboxy-terminals which are able to bind to MHC class I molecules inside of the
endoplasmic reticulum (Bouvier, 2003).
Endogenous peptides must be transported from the cytosol to the
endoplasmic reticulum where they can be bound to class I MHC molecules. The
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proteins responsible for the transportation of endogenous peptides are two
transporters associated with antigen processing -1 and -2 (TAPI and TAP2)
proteins (Lankat-Buttgereit and Tampe, 1999; Lankat-Buttgereit and Tampe,
2002; Townsend et al., 1989).

TAP1 and TAP2 are part of the ATP-binding

cassette family. When these molecules form a heterodimer, the two hydrophobic
transmembrain domains stick into the endoplasmic reticulum while the two ATPbinding cassette domains remain in the cytosol creating a passage way for
peptides from the cytosol to the lumen of the endoplasmic reticulum (Gorbulev et
al., 2001). The TAP genes are located adjacent to one another in the class I
region of the B complex for the chicken but in the class II region for mammals
(Beck, 1999; Kaufman etal., 1999b). Binding of the endogenous peptide to the
MHC class I molecule causes a conformational change in the class I a chains
and the (32-m molecules allowing them to assemble in such a way as to stabilize
the MHC:peptide complex. The stable MHC:peptide complex is then transported
to the Golgi apparatus and then to the cell surface for recognition by CD8+ Tcells (Click et al., 1992; Ljunggren et al., 1990; Townsend et al., 1989).
Class II Surface Antigens
The chicken B-L molecules are expressed on B cells, macrophages, and
other antigen presenting cells. The chicken B-L molecules are homologous to
the mammalian class II molecules (Salomonsen et al., 1991a). The mouse H-2 Iregion is responsible for graft-versus-host reactions and is divided into five
subregions (l-A, l-B, l-J, l-E, and l-C). The class II antigen, B-L proteins of the
chicken, are homologous with mouse Class II (la) antigens (Ewert et al., 1980).
20
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Genetically the mouse H-2 I and human HLA-D regions produce molecules with
similar weights, biochemical, and tissue distribution properties (Pink etal., 1977).
Like the mouse la antigens, B-L antigens are composed of two types of
polypeptide chains: a and p. The four B-L loci encode for two chains of each
type, two a and two (3.' There are two B-L antigens that are homologous with
mouse l-A and l-E products.

Each of the mouse molecules, l-A and l-E,

responds to different antigens just like the two different B-L molecules.

This

suggests that the evolutionary divergence leading to birds and mammals
occurred after the development of B-L and la antigens (Crone et al., 1981). B-L
antigens

reside

on

the

surface

of

Ig

positive

lymphocytes,

monocytes/macrophages and some stimulated T-cells (Peck et al., 1982; Siwek
et al., 2005) (Ewert et al., 1980).

During the inflammatory response

macrophages express increased amounts of B-L antigen on their surfaces
(Golemboski et al., 1989).
Exogenous Route
Class II MHC molecules utilize an exogenous (Morrison et al., 1986)
pathway to present antigenic peptide to CD4+ T-cells (Germain, 1986; Sweetser
et al., 1989). Antigenic peptide for MHC class II molecules is acquired when
antigen

is

taken

up

into

the

APC

by

endocytosis,

macropinocytosis, and sometimes pjnocytosis (Lanzavecchia,

phagocytosis,
1990), into

peripheral endosomal compartments. The acidification, optimally a pH of 4.5-4.4
(Jensen, 1991; Lee and Watts, 1990), of the endosomal vesicle activates
protease to degrade the antigen into peptide fragments of 12-25 amino acids in
21
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length for the appropriate size binding to class II molecules (Harding et al., 1991;
Townsend et al., 1985).

These protein fragments are transported into the

endoplasmic reticulum by TAP1 and TAP2 proteins (Androlewicz et al., 1993).
Meanwhile in the endoplasmic reticulum (ER), an inactive MHC class II
molecule is waiting for antigenic peptide. The MHC class II molecule inactive
form is comprised of three main parts, the ll-associated invariant chain peptide
(CLIP), the a subunit, and the p subunit. The a and p subunits provide the main
form of the class II molecule while the CLIP is essential for class II assembly
(Anderson and Miller, 1992), endosomal location (Schaiff et al., 1992),
association with antigenic peptide (Stockinger et al., 1989), cell surface
expression (Sekaly et al., 1986), and functional interactions with CD4+ T cells
(Sant and Miller, 1994).

The importance of the CLIP is most prominently

observed in CLIP knock out mice where class II expression is impaired (Bikoff et
al., 1993; Viville et al., 1993).

While in the ER, the MHC class II molecule

remains inactive because of the CLIP. The CLIP binds to the class II molecule
active site preventing it from binding to self peptide (Elliott et al., 1987).
Therefore, in order for the class II molecule to become active, CLIP must be
removed. The a and p dimers alone that are capable of binding to antigenic
peptides (Roche and Cresswell, 1990).
Once stimulated the class II molecule with the invariant chain leaves the
ER, is transported by the Golgi apparatus, and released into an early endosome
which then becomes a prelysosome. During this period of transition the class II
molecule loses association with the invariant chain. Binding of class II molecules
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with peptide antigen occurs when a lysosomes containing peptide antigen fuses
with the endosome bearing the class II molecule becoming the phagolysosome.
The class II molecule is able to bind to the antigenic peptide and present it on the
surface of the APC for CD4+ T cell receptors (Lanzavecchia et al., 1992).
Class III Proteins
The major histocompatibility complex class III genes encode for proteins
that are more commonly known complement system proteins. Complement is a
system of plasma proteins that bind to microbial antigen surfaces making them
for destruction by phagocytic cells. Complement is also an immune response
that is capable of attacking a broader range of antigens than the class I or class II
MHC molecules.

Complement activation occurs via three pathways, the

classical, the alternative, and the lectin.

The classical pathway is antibody

dependent. B-cells which make antibodies, in addition to B-cell receptors (BCR)
that bind to antigens, have complement receptors (CR).

When complement

protein (C3b) binds to the CR the BCR and CR cross link stimulating the B-cell to
produce antibodies that will tag the pathogen for opsonization by phagocytes. In
the alternative pathway, complement protein C3b identifies amino or hydroxyl
groups that are present on several bacteria.

The complement proteins work

together to form pores known as the membrane attach complex in the pathogen
membrane which disrupts osmolality of the cell causing it to lyse. In the lectin
pathway, mannin binding lectin proteins (MBLP) produced by the liver and in
circulation in the blood bind to lectin, a protein present on the surface of common
pathogens. MBLP also forms a MAC leading to cell lysis.
23
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The classical pathway is stimulated by IgG or IgM binding to the antigen to
form the antigen-antibody complex. C1 (complement 1) is then bound to the
antigen- antibody complex initiating the classical pathway enzymatic cascade
(Augener et al., 1971b; Muller-Eberhard, 1975). In the inactive form, C1 is a
complex composed of three parts; C1q a single molecule bound to two zymogen
molecules C1r and C1s. The C1q molecule has six globular heads, linked by a
collagen-like tail. When more than one of the C1q heads binds to the surface of
a pathogen or to the Fc portion of an IgG or IgM antibody there is a
conformational change in the C1 molecule.

The conformation change in C1

activates the autocatalytic enzymatic activity in C1r.

C1r then cleaves its

associated C1s generating an active serine protease (Augener et al., 1971a;
Becker, 1956).
The C1s active protease then cleaves C4 to C4a and C4b which binds
covalently to the surface of the pathogen. C4a is released as a peptide mediator
into the body. Antigen bound C4b binds to one C2 molecule (Lepow et al.,
1963). C2 is then cleaved by the activated serine protease C1s in to C2a and
C2b (Polley and Muller-Eberhard, 1968).

This cleavage forms the C4b:C2b

(c4b2b) complex otherwise known as C3 convertase (Muller-Eberhard et al.,
1967). The C2a molecule is released into the body as a precursor of vasoactive
C2 kinin (Borsos and Rapp, 1963). Activated C3 can cleave up to 100 molecules
of C3 forming C3a and C3b.

C3a is released as a peptide mediator for

inflammation while C3b binds to the surface of the antigen coating. C3b is the
main molecule of the complement pathway whose binding marks a pathogen as
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a target for destruction by phagocytes that have receptors for C3b. C3b also
binds to C3 convertase to form C5 convertase. C5 convertase cleaves C5 to
generate C5a and C5b. C5a is a small peptide mediator of inflammation that is
released. One of the ways that the activation of the classical pathway destroys
pathogen is by assembling the membrane-attack complex (MAC) (Peitsch and
Tschopp, 1991). The end result of this complex is a pore in the lipid bilayer
membrane of the cell that destroys the membrane’s integrity. These pores cause
disruption of the protein gradient along the membrane leading to lysis of the cell.
C5b is the first step in the assembly of the membrane-attack complex.
C5b binds to one molecule of C6 and then to one molecule of C7. This complex
leads to a conformational change exposing their hydrophobic site on C7 making
insertion into the lipid membrane bilayer possible. When the C5b:C6:C7 complex
binds to C8 and C9, conformational changes occur exposing their hydrophobic
site as well. C8 is composed of C8|3 and C8a-y. C8(B binds to C5b and C8a-y
binds to the C5b:C6:C7 complex and inserts itself into the lipid bilayer. Then
C8a-y induces the polymerization of 10 to 16 molecules of C9. C9 polymerizes
the C5b:C6:C7:C8 molecule to form the MAC (pore in the bilayer lipid
membrane), which disrupts the water and protein gradient in the cell lysing it
(DiScipio etal., 1984; Marazziti etal., 1988; Stanley etal., 1985).
Class IV Molecules
In addition to class I and class II the B complex encodes for a third class
of molecules, the class IV or B-G molecules. Class IV molecules are encoded in
the B-G gene region of the B complex. B-G proteins are unique to the chicken
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cells (Neu et al., 1984). Originally B-G antigens were only thought to be on the
surface of erythrocytes and erythrocyte precursors (Longenecker and Mosmann,
1980b; Miller et al., 1982; Salomonsen et al., 1987); however, they were also
present on the cell surface of thrombocytes, lymphocytes, some epithelial cells in
the bursa, thymic lymphoblasts, hepatocytes, and stromal cells (Salomonsen et
al., 1991a).
B-G molecules are recognized by the immune system in a different way
from either class I or class II molecules (Kaufman et al., 1990a).

The B-G

epitopes on chicken red blood cells are recognized by certain cells in the human,
rat, mouse, and alligator. By using animals that were not immunized to CRBC’s
rosette-forming cell assays revealed that these animals would produce
antibodies specific to the B-G epitopes on CRBC’s (Salomonsen et al., 1991b).
This lead to the idea of “natural antibody” (Longenecker and Mosmann, 1980a),
meaning that other species would identify the B-G epitope stimulating an innate
immune response (Longenecker and Mosmann, 1980a; Neu etal., 1984).
B-G genes are in the B complex (MHC) on microchromosome 16 and are
linked with the NOR of that chromosome (Guillemot et al., 1989b; Skjodt et al.,
1985).

B-G genes are also closely linked to B-F/B-L gene regions (0.05cM)

(Kaufman et al., 1991)

The theorized purpose of the B-G molecules is to

enhance antigen recognition by B and T cells thereby enhancing antibody
response. This effect is more commonly noted as being an adjuvant effect to
antigen (Salomonsen et al., 1991a)

26

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Antigen Processing and Presentation
Antigen Presenting Cells (APC)
The adaptive response is coordination between MHC molecules in antigen
presenting cells, T-cells, and B-cells.

Other players in the adaptive immune

response include; T-cell receptors (TcR), immunoglobulins (Ig), secreted proteins
such as cytokines, and macrophages (Janeway, 2005). There are three main
types of antigen presenting cells; B cells, macrophages, and dendritic cells (DC).
B Cells
B-cells are part of the acquired immune system’s humoral response to
antigen. The main job of B-cells is to produce antibodies specific to a particular
pathogen. The B-cell does this through a process known as clonal selection.
The B-cell has receptors on its surface that bind specifically to its cognate
antigen, the antigen that has a specific epitope for the B-cell receptor (BCR).
Immunoglobulins (Ig) produced by a specific B-cell also share that specificity for
only that particular epitope.

When a B-cell makes contact with it’s cognate

epitope it’s BCRs crosslink sending a signal to the nucleus to begin dividing into
daughter cells.
Some antigens have repeat epitopes that the B-cell receptor is able to
bind. These repeat (i.e. carbohydrate on bacteria) epitopes can be enough to
cause BCR crosslinking. Crosslinking of BCRs is key in the activation of a B-cell;
however, crosslinking alone is not enough to cause activation. B-cells will not
produce antibodies until they receive a second (co-stimulatory) signal. This (co-
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stimulatory) signal can happen in one of two ways: either T-cell dependent or Tcell independent. A co-stimulatory signal may be initiated by an activated helper
T-cell when it’s CD40L cell surface protein ligates the protein CD40 on the cell
surface of the B-cell. The second way a co-stimulatory signal may occur is T-cell
independent. T-cell independent co-stimulatory signals come in the form of a
cytokine. IFN-y is produced by activated macrophages and Natural Killer cells
(NK). IFN-y is a clear signal that a pathogen is in the area and that these cells
are already fighting it. This two signal system for activation of the B-cell insures
that the B-cell will only be activated in the presence of pathogen.
Although each B-cell has thousands of B-cell receptors (BCR) on it they all
bind to the same cognate antigen. Once bound to a cognate antigen the B-cell
begins to proliferate, replicating itself into daughter cells.

Each cycle of cell

growth and divisiori takes about 12 hours until there are about 20,000 identical Bcells.

These B-cells then receive their co-stimulatory signal and mature into

Plasma cells, which produce Ig specific for the same cognate antigen as the
BCR.
There are five classes of immunoglobulins: IgA, IgD, IgE, IgG, and IgM.
When a B-cell is mature and producing Ig it is known as a plasma cell. Each Ig
type has a unique shape and therefore function. The Ig class is determined by
the heavy chain. The Fc region distinguishes the shape of the antibody rather
than its antigen binding.
There are estimated to be 107 to 108 distinct antigens.

Since most

vertebrate genomes do not encode more than 30,000 to 35,000 distinct genes,
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one can assume that these genomes do not encompass distinct genes to encode
each antibody in response to each type of pathogen.

In order to have an

effective repertoire of antibody molecules to respond to many different types of
pathogens, B-cells have the ability to recombine Ig gene segments (Lieber,
1991). The B-cell receptor (BCR) is made up of two proteins the heavy chain
(He) and the light chain (Lc).
genes V, D, J, and C.

These chains are encoded by four families of

Joining different members of these families creates

diversity.
There is a dramatic difference between the development of immature Bcells to plasma cells in humans, frogs, and sharks as compared to that of
chickens, rabbits, and sheep. In the first group B-cells develop in bone marrow
where lymphopoiesis is free of exogenous antigen.

However, in the second

group, that includes the chicken, B-lymphocytes develop in gut-associated
lymphoid tissue. Specifically, the ileal Beyer’s patches in sheep (Reynaud etal.,
1995; Reynaud et al., 1991), the rabbit appendix (Becker and Knight, 1990;
Knight, 1992), and the avian bursa of Fabricius (Glick, 1956; Langman and Cohn,
1993; Ratcliffe and Paramithiotis, 1990; Weill and Reynaud, 1987).

Here the

developing B-cells are exposed to gut-derived exogenous antigens (Bockman
and Cooper, 1973; Sorvari et al., 1975). Glick et al,. (1956) first established that
B (Bursa-derived) lymphocytes were the source of antibody production. Chicks
whose bursa of Fabricius had been surgically removed were inoculated with
Salmonella typhimurium type O antigen. The antibody response of the chicks to
the inoculation was then measured and no antibody response was found in those
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chicks whose bursa had been removed.

Control chicks, whose bursa of

Fabricius had not been removed, were inoculated with Salmonella typhimurium
type O antigen as well. The control chicks did produce antibodies to Salmonella
typhimurium type O antigen (Glick, 1956; Glick and Whatley, 1967). This study
established the bursa of Fabricius as the site of B-cell development in the
chicken.

Unlike in the human, bone marrow had no set role in B-cell

development for the chicken.
Chicken B-cells rearrange their V, D, J, and C gene regions to produce a
variety of BCR. Between five and seven days of embryogenesis cells in the prebursal compartment commit to B cell lineage by the rearrangement of the D and
J gene regions (Reynaud et al., 1992). Cells then migrate to the splenic anlage
sites of hematopoiesis within the embryo proper where splenic cells commit to Bcell differentiation by undergoing V J rearrangement (McCormack and
Thompson, 1990). VJ rearrangement success is apparent if the B-cells produce
the cell-specific antibody Bu-1. At day 13 of embryogenesis about 20-25% of
splenic cells are Bu-1 positive (Houssaint et al., 1989). At this point Bu-1 positive
cells migrate to the bursa of Fabricius where they begin clonal expansion. The
migration occurs in Bu-1 positive cells that are also positive for the selection of
sialyl Lewis x. It is sialyl Lewis x that dictates these cells to migrate to the bursa
of Fabricius. Sialyl Lewis x is a protein responsible for vascular homing, in this
case it homes these Bu-1 positive cells to the bursa of Fabricius (Pickel et al.,
1993). These cells are exposed to self antigen within the bursas and therefore
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remain inside of the bursa of Fabricius and are specific against bursa specific
antigen.
In order for these cells to make the switch from identifying self antigen of
the bursa of Fabricius to identifying foreign antigen the VJ region must go
through the process of gene conversion.

The bursa of Fabricius plays an

essential role in the B-cell diversification (McCormack et al., 1993b). Unlike the
human, the chicken B-cell has only a single V region and a single J region in both
the Ig light and heavy chain genes. In the human V(J)D gene rearrangement
creates enough diversity in Ig heavy and light chains to build ample receptors for
many pathogens.

However, because the chicken has fewer V and J regions

rearrangement of the V(J)D genes is sufficient enough to commit a B-cell to
development and brings together these elements to form a single antigen-binding
domain exon (Reynaud et al., 1987),

but not sufficient enough to create a

diverse selection of Ig’s (Reynaud etal., 1985; Reynaud etal., 1989). Therefore,
the V(J)D gene region in the chicken utilizes gene conversion to develop diversity
among Ig’s (McCormacketal., 1989).
In the chicken, gene conversion is a process in which sequenced
information is transferred unidirectionally from pseudo-V genes to the rearrange
V region of the germline. This unidirectional, multiple, and random sequencing
can happen seven to ten times to a developing B-cell within the bursa of
Fabricius.

Once the B-cells have undergone gene conversion through the

sequencing of information in pseudo V genes to functional V genes there are at
least 1011 different potential Ig’s (Tjoelker et al., 1990). Once diversification has
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occurred the B-cells surface proteins change from Lewis x-high to Lewis x-low
and the B-cells are able to migrate throughout the body (McCormack et al.,
1993a).
Once an antigen is cleared from the system, most of the B-cells die.
However, some remain as memory cells ready to launch a quicker and more
powerful antibody response upon second contact with it’s specific antigen.
Memory B-cells are the reason we can expect to see greater antibody response
in the secondary response to antigen than in the primary response to antigen.
Chicken Immunoglobulin (la) Diversity
Immunoglobulins (Ig) are embedded (n the surface of B cells, on mucosal
surfaces, or in circulation when secreted by plasma cells as antibodies. The
diversity and amount of Ig are important factors in disease resistance and
susceptibility (Janeway, 2005). Like the BCR, Ig consist of two light chains (Lc)
and two heavy chains (He). An Ig is shaped like a Y with the two light chain
regions being identical. The antigen binding regions of the Ig are comprised of
the ends of light and heavy chains and are known as the Fab regions. The third
region is known as the Fc region which binds to Fc receptors on the surface of
cells like macrophages.
The chicken B cell is capable of producing three different Ig types IgM,
IgY, and IgA (Magor et al., 1998). Two main antibodies produced in the chicken
are IgM and IgY. IgY has the same number of secretory exons as IgE; however,
IgY’s RNA processes are more similar with IgG.

The common similarities

between IgG and IgE found in IgY suggest that IgG and IgE evolved from IgY
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(Magor et al., 1994; Warr et al., 1995). IgM looks like five IgY molecules in a
circle with their Fab receptors pointed outwards. Antibodies are distinguished by
their heavy chains or Fc regions. Antibodies are converted from one isotope to
another through class switching. In class switching, some gene segments that
encode for the constant region in IgM are cut out, or deleted, from the sequence.
The remaining sequence codes for a different Fc region and therefore a different
antibody isotope. A B-cell can produce different types of antibodies that will have
the same antigen binding regions but different Fc regions which determine how
the antibody can function. IgM is the default antibody class and the first isotope
to be synthesized when a B-cell becomes activated for the first time. In order for
IgY molecules to be produced class switching must occur. Because IgM is the
default antibody, there will be more of it present in the primary antibody response
to antigen than the secondary. In the secondary antibody response IgY is the
primary antibody. Because of their similar forms, IgY can be measured using the
same experimental procedures used when measuring IgG. (Petersen et al.,
2001 ).

Dendritic Cells (DC)
Langerhans cells are an example of immature dendritic cells that live just
below the skin. Dendritic cells, in general, reside all over the body in peripheral
tissues and organs, in their inactive state.

In their immature state, they are

unable to stimulate T-cells because they lack co-stimulatory B7 molecules and
have few MHC class II molecules expressed.

While in their inactive state

dendritic cells are constantly “drinking” or engulfing pathogens via phagocytosis
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through receptors such as lectin DEC 205 that recognize antigen by pattern
recognition.
When the dendritic cells capture an antigen, the cell is stimulated by
cytokines to migrate to lymph organs where they come into contact with naive Tcells. Once in the lymph tissue, dendritic cells stop phagocytosis and produce
dendritic cells-CK (CCL18), a chemokine that attracts naive T-cells.

Here

dendritic cells express high levels of MHC class I and MHC class II molecules, as
well as adhesion molecules dendritic cells-SIGN and B7.

These molecules

combined make the dendritic cells able to present antigen.
Macrophages
Macrophages, like dendritic cells, reside all over the body.

However,

unlike dendritic cells macrophages do not travel to surrounding tissue during
infection.

Like dendritic cells, macrophages only express enough MHC

molecules and B7 to act as APC after interactions with cytokines (IFN-y in the
case of macrophages). If macrophages don’t go to the T-cell, the T-cell must
come to the macrophage. This is exactly what happens. Macrophages stay at
the sight of infection to re-stimulate T-cells through constant antigen presentation
as long as antigen is present.
Macrophages have two options when presented with antigen. The first
option is to phagocytose the antigen and destroy it. If the macrophage cannot
destroy the antigen the second option it has is to be broken down enzymatically
and loaded into MHC class I molecules for T-cell presentation.
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T-Cell Development
While B-cells develop in the bursa of Fabricius, T-cells develop in the
thymus (Cooper etal., 1966; Warner, 1965). The T-cell repertoire is not created
through gene conversion as the B-cell’s is but rather through the rearrangement
of T-cell receptor mini genes (Cooper et al., 1991).
During embryogenesis, the chicken thymus contains T-cell precursors
(Coltey et at., 1987). Three T-cell subpopulations emerge during development
TCR1, TCR2, and TCR3 in that order (Char et al., 1990). T-cell migration from
the thymus to the periphery follows in order of T-cell subpopulation development
(Char et al., 1990). These T-cells are distinguished by their T-cell receptor’s
(TCR).

Similar to the human TCR, the T-cell receptors of avian species are

multi-chain transmembrane heterodimers comprised of four transmembrane
glycoprotein chains designated; a, p, y, and 5. The two glycoprotein polypeptide
chains, T-cell receptor a (TCRa) and T-cell receptor (3 (TCR{3), are paired and
bound by a disulfide bond to form a disulfide-linked heterodimer. The TCRy and
TCR6 glycoprotein polypeptide chains are also linked in the same fashion (Chen
et al., 1986). Each of the a and [3 chains contains a constant region, closest to
the T-cell surface, adjacent to a variable region which is attached to the antigenbinding site. The apTCR is present on TCR1 T-cells (Sowder et al., 1988) while
the ySTCR are present on TCR2 and TCR3 T-cells (Chen et al., 1988).
Both af3TCR and y5TCR are noncovalently associated with a CD3 protein
complex to form a signal transduction unit. The CD3 complex in the chicken is
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homologous to that in mammals since all four of it’s glycoprotein chains, y> 6. 6.
and £ have been found to be homologous (Chen et al., 1986).
CD4 and CD8 coreceptors have been identified in the chicken and found
to be homologous to those found in mammals (Chan et al., 1988). The CD4
coreceptor is a single peptide and the CD8 receptor is a disulfide-linked dimer.
Chains CD8a and p are expressed in both chickens and mammals .

This

expression forms the chicken hetero- and homodimers CD8aP and CD8aa
respectively (Tregaskes et al., 1995). Also, the CD4 and CD8 coreceptors are
associated with a mammalian homologous tyrosine protein kinase p56lck
(Veillette and Ratcliffe, 1991). The CB3 molecule expressed on avian cells is a
cell surface glycoprotein that is homologous to mammalian p2-microglobulin in
mammalian class l-like molecules (Pickel et al., 1990).

CD4, CD8, and CD3

molecules have similar molecular weights, tissue distribution and function to their
mammalian counterparts (Cooper et al., 1991).
TCR’s and associated molecules appear to have developed before the
divergence of avian and mammalian species. Therefore, it should be no surprise
that mammalian CD4 and CD8 surface proteins have homologous surface
proteins on chicken T-cells (Chan et al., 1988).

Also, the TCR recognition

system is the same due to it’s preservation in avian and mammal systems over
the past 250-300 million years of divergent evolution (Tjoelker et al., 1990).
How TCR1. TCR2. and TCR3 Function
The ySTCR TCR1 comprises as much as 50%, but usually 20-25% of the
T-cell population in the chicken. This is different from both the human and the
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mouse where only a minor subset of the T-cell population is comprised of TCR1
(Haas et al., 1993).

TCR1 cells rapidly leave the thymus where they do not

express CD4 and CD8 (Bucy et al., 1990) and proceed to the sinusolidal areas
of the spleen and the epithelium of the intestines (Bucy et al., 1988).

After

migration, CD8 coreceptors appear on the TCR1 (Sowder et al., 1988). The
CD8+ y5 TCR1 cells function to down regulate the immune response (Quere and
Thorbecke, 1992; Quere and Thorbecke, 1991) although they are not involved in
host vs graft reactions (Bucy et al., 1989).
The two apTCR, TCR2 and TCR3, play a role in graft vs host tolerance
and reactions vary depending on donor and recipient MHC combinations
(Maccubbin and Schierman, 1986). Both TCR2+ and TCR3+ ap T-cells express
either CD4 or CD8 coreceptor molecules where TCR1 usually does not express
either (Chan et al., 1988).
T Cell Receptor Diversity
A T-cell receptor has only one antigen binding site whose specificity
comes from highly polymorphic membrane-bound heterodimers (Al-Lazikani et
al., 2000; Dembic et al., 1986). However, the T-cell receptor is diverse due to
rearrangement of multiple T-cell receptor genes, coding for the variable domain.
The TCRP locus has four segments which are homologous to mammalian
counterparts, they are variable (V), Diversity (D), joining (J), and constant (C)
(Tjoelker et al., 1990). The C region is identical to the C region in mammals.
The V-D-J segments recombine to create TCRP diversity (Lahti et al., 1991;
Tjoelker et al., 1990).

These gene segments are relatively simple, when
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compared to those of humans, as the Vp segment has only two gene segment
families V p i and VP2. v p t has 17 gene segments in it’s family while Vp2 has 35 gene segments (Dunon et al., 1994). Also, there is only one segment for both
J and D (Tjoelker et al., 1990). With the limited ability for recombination among
such a small number of gene segments the diversity for TCRP is acquired via the
recombination of VD and DJ segments in the CDR3 sequence (McCormack et
al., 1991). All together the TCRP locus codes for approximately 300 amino acids
that include cysteine residues that form intra- and interdisulfide bonds and a
positively charged lysine that forms a salt bridge with a negatively charged amino
acid of CD3 molecules. There is 30% overall amino acid sequence identity with
mammalian TCRP chains (Kroemer et al., 1990).
The TCRa genes have one J segment and one Va family with 25
members. Here a single exon codes for both light chain (La) and variable chain
(Va). These genes code for approximately 275 amino acids of the TCRa chain
which contains V, J, and G regions.

The chicken TCRa chain shares 26%

homology with that of the human; however, most of the structural integrity of the
mammalian TCRa and the chicken TCRa has been conserved (Kaufman et al.,
1999b).
Because TCR2 and TCR3 are subsets of TCR1, it should be no surprise
that they both contain Ca and Cp mRNA and the same Dp and Jp segments.
Their differences lie in the V gene segments where TCR2 contains only V pi
gene segments and TCR3 contains only VP2 gene segments (Lahti et al., 1991).
This subdivision of chain sequences is also found in mammalian TCRP chain
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sequences which can be subdivided into Vpi and Vpll (Schiffer et al., 1986). The
chicken and mammals have the same structural features in these subgroups
(Tjoelker et al., 1990). There is only approximately 24% homology between Va1
and Va2 family members although both TGR2 and TCR3 can use Va2 members.
Therefore, it is likely that the v p i and Vp2 genes are goverining the functional
differences in TCR2 and TCR3 T-cells (Kaufman et al., 1999b).
T-Cell Activation
One of the central features of immunity in the chicken and all vertebrate
animals is the ability of T-cells to recognize foreign antigen and invoke a cellmediated immune response (Cohn, 1983). T-cells do not act alone to elicit an
immune response. Instead T-cells must be activated by MHC bound antigenic
peptide expressed on the surface of antigen presenting cells (APC).

In the

chicken and other vertebrates, T-cells are activated by interactions between
antigenic peptide bound to MHC molecules and TCR’s (Vainio et al., 1988).
T-cell activation involves interaction between the TCR2+ and TCR3+ ap
T-cell and co-receptors (CD4+ or CD8+) and the MHC peptide complex. T-cells
under the control of B-L genes within the B complex express CD4+ co receptor
molecules and interact with MHC class II molecules (Kaufman et al., 1990b).
T-cells under the control of B-F genes express CD8+ coreceptors and interact
with MHC class I molecules (Pink et al., 1977).

This interaction causes

costimulatory signals to be passed in both directions stimulating the effector
functions of the T-cell.
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The molecule most known for these co stimulatory signals is CD28 which
is present on CD4+ and CD8+ T-cells (Ratcliffe et al., 1993). CD28 is associated
with the stabilization and enhancement of cytokine production. The ligand for
CD28 in the mouse is known as B7 (CD80 in the human) and there has been
homology found between this molecule and BG molecules of the chicken (Linsley
et al., 1994). Activation of CD4+ T-cells produces cytokines that are received
locally by APC augmenting their function.

For example, a macrophage

stimulated by cytokines produced by activated CD4+ T-cells may take on
phagocytic functions (Lassila et al., 1988).
The two different classes of MHC molecules (I and II) are responsible for
binding peptide fragments of antigens and bringing them to the cells surface for
presentation to the T-cell. Whether a class I or class II molecule presents the
antigen peptide fragment depends upon where that fragment is conceived.
Antigen must first be broken down into peptides to bind to MHC molecules.
Antigens are characterized as exogenous meaning created outside of the body
or endogenous meaning created inside of the body. Exogenous antigens will be
processed into peptides in acid vesicles and therefore bind to class II MHC
molecules.

Exogenous antigens include bacteria, viruses taken up by

macrophages (dead viruses), and other potentially harmless foreign proteins
such bovine red blood cells (BRBC) that are developed outside of the body and
invade it whole.

Endogenous peptides are generated in the cytoplasm and

endoplasmic reticulum and therefore bind to class

I MHC molecules.
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Endogenous antigens are usually live viruses and their products that develop
antigens inside the body’s own cells.
Genetic Resistance to Disease
Resistance to disease is determined by genetic and environmental factors.
The basis for disease prevention is self and non self recognition of antigens by
the immune system (Janeway, 2005).

There appear to be multiple genetic

factors determining the strength of self non-self recognition in Gallus gallus
domesticus (chicken). The genetic factors include the MHC, but are not limited
to this region (Cheeseman et al., 2004). To compare MHC gene effects without
the influence of other genes, congenic chicken lines are valuable.

Congenic

chicken lines are inbred lines that differ genetically from one another by only a
small genetic region (Zaleski et al., 1983). To understand how a congenic line is
established, we must first understand the genetic differences between inbred and
outbred animals.
Outbred Animals
In outbred populations, heterozygote and homozygote allele frequencies
are predictable according to the Hardy-Weinberg equilibrium as long as the
organism and its population meet specific criteria.

The organism must:

reproduce sexually, be diploid, and utilize discrete generations. Matings within
an infinite population size must not experience: selection, mutation, or migration.
If two mating individuals are heterozygous for non linked alleles (e.g., Bb), then:
25% of their offspring are homozygous for the dominant allele (BB), 50% are
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heterozygous like their parents (Bb), and 25% are homozygous for the recessive
allele (bb) and, thus, unlike their parents, express the recessive phenotype.
According to the Hardy-Weinberg equilibrium, the frequencies of allele B and b
remain constant, within a population from generation to generation (Hardy, 1908;
Weinberg, 1908).
Inbred Strains
Inbred strains are homozygous for their allele composition.

Nelson

Waters initiated the formation of 15 inbred chicken lines at the Regional Poultry
Research Laboratory (RPRL) in East Lansing, Michigan.

These lines were

developed for researchers to discern genetic agents from environmental effects
in their investigations of avian disease (Brandly and Waters, 1948). In 1939,
Waters took 1,000 hatched eggs from 10 different flocks of White Leghorn
Chickens. The chicks were divided into two groups, one that was quarantined
and the other that was exposed to suspensions of avian leukosis complex (ALC,
also known as Marek’s disease (MD)) tumor materials in non-quarantined
housing. Interstrain and intrastrain crosses were made while selecting for the
most or the least desirable characteristics. Later, different levels of inbreeding
were utilized to establish 15 lines known as lines 1-15. With the exception of line
10 all of the lines mated sires from one strain with dams from one or more
strains. Line 10’s ancestry evolved from a single dame and single sire from the
same original strain.

In the 1940s, high incidence of lymphoid leukosis B-cell

lymphomagenesis (LL) broke out among the quarantined birds (Biely etal., 1932;
Warrack and Dalling, 1932). Transmission of the disease was suspected to be
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vertical by parent to offspring. However, some families were free of infection.
Those families that were disease free were selected. In all, 22 dams from line 15
were used for breeding.

The progeny produced from these breedings were

moved to a new quarantined house and isolated for 300 days. At the end of the
isolation period only 6% of the birds had LL mortality with two families showing
no signs of LL mortality. The two families without LL mortality were selected to
develop the first LL free line of birds grown in isolation known as Line 151 (Waters
and Prickett, 1944). Over time certain lines with undesirable characteristics were
eliminated from the study.

By 1951, only lines 6, 7, 9, 10, 14, 15, and 151

remained (Waters, 1951; Waters and Fontes, 1960). Only lines 6, 7, 15 and 151
remained from Waters original 15 lines by 1966 .
Waters work was continued by Lyman Crittenden beginning in 1962 when
he introduced artificial insemination and brother-sister mating to inbreeding.
Assortative breeding or inbreeding changes the allele frequencies by producing
an increasingly homogenous population with successive generations. Full sibling
mating is the quickest way to increase genetic homozygosity (Crittenden, 1961).
This increased homozygosity is why the Hardy-Weinberg law does not apply to
sister-brother mating for multiple generations (Klug et al., 2006; Zaleski et al.,
1983). Sibling matings using the lines established by Waters created sublines
within the inbred lines.
Crittenden exposed Lines 6 and 7 to Avian Leukosis Virus (ALV) subgroup
A and B Rous Sarcoma Virus (RSV), and Marek’s disease virus (MDV). MD is a
lymphoproliferative disease (T cell cancer) caused by the Marek’s disease virus
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(MDV).

MDV is a member of the herpesvirus family that causes a

lymphoperliferation of T cells. Chickens infected with avian leukosis virus (ALV)
often contract B cell cancers. Line 6 was quite resistant to ALV (subgroup A and
B) and resistant to MD. Line 7 was resistant to ALV (subgroup A), susceptible to
tumors induced by MD, and selected for resistance to ALV (subgroup B)
(Crittenden et al., 1967).
Line 100 was established to be a line susceptible to MD but resistance to
ALV subgroups. Line 100 bred four Line 6 sires with six Line 7 dams to produce
the Fi progeny. Dams from the Fi progeny were then backcrossed to Line 7
sires.

Dams in this next generation were tested for ALV (subgroup A)

susceptibility through inoculation with RSV. Four consecutive backcrosses later
the newly formed Line 100 was comprised 97% of genetic material from Line 7
(Crittenden et al., 1964). When Line 100 was exposed to ALV (subgroup B) sub
lines were formed based on resistance to the subgroup B virus.
Recombinant Conaenic Strains
Avian Disease and Oncology Laboratory (ADOL) line 6 has the B2/B2
MHC genotype.

This line of chickens is resistant to MD, LL, and regresses

tumors caused by RSV. ADOL line 15 has the B5/B5 genotype.

Line 15 is

susceptible to MD, LL, and progresses tumor growth caused RSV. When these
two lines were crossed the progeny genotypes were tested for susceptibility and
resistance to MD, LL, and tumors caused by RSV.

Progeny with genotypes

B2B2 and B2B5 regressed most sarcomas while progeny with the genotype
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B5B5 progressed and metastasized most sarcomas.

Next, congenic chicken

lines were used to study the effects of the B complex on immune response.
A congenic line is a line of chickens that are backcrossed over 10
generations until 99.99% of their DNA is the same. Between lines of congenic
chickens, background DNA is the same while a small genetic region being
studied differs.

The inbreeding coefficient is used to calculate the percent

homology between inbred individuals. The inbreeding coefficient is calculated by
Ic = 1 - (1 - lr)9 where Ic is the inbreeding coefficient read as a percent, Ir is the
inbreeding rate, which for sibling mating is 0.191, and g represents the number of
consecutive generations undergoing inbreeding. Genome purity where 99.99%
of the genes are homozygous among individuals is obtained after 60 generations
of sibling inbreeding.
A congenic line has identical background DNA but differs by a single gene
or allele known as the differential gene. In establishing a congenic line, an initial
cross is made between a differential strain (a chicken that has the desired gene,
which does not have to be inbred) and an inbred line called the background line.
After selecting for the desired gene, and backcrossing for 12 generations a new
congenic strain is formed with the differential gene.
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MHC Recombinants and Disease
Marek’s disease (MD) is a malignant chicken lymphoma that is caused by
a herpes virus known as Marek’s disease virus (MDV).

MD has the greatest

economic impact for poultry production when compared to all other chicken
pathogens,

in 1968, Cole published findings that demonstrated a strong

heritability in the outcome of tumor formation after exposure to MDV. Cole used
Cornell breeding populations and segregated chickens into families depending
on their resistance (N) or susceptibility (P) to the formation of MD tumors (Cole,
1968). Soon after, the genetic traits observed in Coles experiment were mapped
to the B complex. B haplotype is an essential factor in determining the extent of
either susceptibility or resistances to MDV. The N line having the B21 haplotype
demonstrated 95% resistance to MDV, whereas 100% mortality was seen
amongst the P line of chickens that possessed an excess of the B19 haplotype
(Briles and Stone, 1975; Briles et al., 1977; Longenecker et al., 1977).

In

congenic studies where the heterozygous haplotype included B21 (B21B19 or
B21B14), the presence of B21 was enough to provide effective resistance to MD
(Briles etal., 1977; Longenecker et al., 1976; Longenecker et al., 1977).
In studies that used congenic lines based on Line UCD-003 to examine B
haplotype in relationship to tumors caused by MDV, haplotypes B2, B6, and B21
were highly resistant to MD. On the other hand, B3, B5, B13, B15, B18, B19,
B24, and B27 haplotypes were susceptible to MD (Abplanalp et al., 1985; Briles
et al., 1980; Schat et al., 1981).
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• When a spontaneous recombination between BF21 and BG19 produced
BF21-G19 and BF19*G19 haplotype chickens, differences in MDV susceptibility
occurred.

Chickens homozygous for B haplotype, BF21-G21, were resistant

while the homozygous, BF19-G19, haplotypes were susceptible to MDV. When
BF21-G19 was exposed to MD the BF21-G19 haplotype demonstrated equal
resistance to MD as the resistant BF21-G21 haplotype.

This experiment

demonstrated that genes closely linked to or within the B-F/BL region are
responsible for resistance to MD (Briles et al., 1983). The BF19-G19 chickens
were susceptible to sarcomas caused by MDV.

Therefore, resistance and

susceptibility to MD is connected with the class I region of the B complex known
as B-F region, but not with the BG region of the B complex (Briles et al., 1983).
MHC haplotypes that express fewer class I molecules, such as B21, are resistant
to MDV, while haplotypes that express more class I molecules, such as B19, are
susceptible to tumor formation (Briles et al., 1983; Gavora and Spencer, 1979;
Plachy et al., 1984).
MHC Gene Dose Effects
B haplotype affects chemotaxis movement of mononuclear leukocytes.
Through the crossing of trisomic chickens these findings were established in
studies that used the disomic (B15B15), trisomic (B15B15B15), and tetrasomic
(B15B15B15B15) progeny of these matings. When compared with the disomic
progeny (B15B15), in experiments that looked at the opsonization of SRBC, the
tetrasomic and trisomic peritoneal macrophages had the same phagocytic
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activity for opsonized SRBC as the disomic macrophages but increased activity
for unopsonized SRBC (Qureshi et al., 1988).
In studies done at the University of New Hampshire, aneuploid effects on
tumor regression or progression of chickens inoculated with RSV subgroup A
were examined. When crossing UNH line UNH 193, trisomic for chromosome 16
(B19B19B19), three progeny types were produced, disomic (B19B19), trisomic
(B19B19B19) and tetrasomic (B19B19B19B19).

When comparing these

progeny’s tumor response to RSV subgroup A, most of the trisomic chickens
regressed tumors the most while the disomic chickens showed significantly less
tumor regression and the tetrasomic chickens did not significantly differ from
either the disomic or trisomic (Taylor, 2004).
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Antibody Response against Bovine Red Blood Cells (BRBC)
Bovine or sheep erythrocytes (BRBC or SRBC) act in stimulating the
immune response, in the form of antibody response, through the activation of the
exogenous antigens pathway. When antigens are phagocytized by APC, their
peptide is then presented at the APC surface by MHC class II molecules. This
antigen-MHC class II molecule complex is recognized by helper T-cells. Helper
T-cells activate B lymphocytes to produce Ig. On first encounter of the antigen Bcells will produce a primary antibody response which mostly consists of IgM.
Once the antigen is cleared most of the B-cells will die, but a few will remain as
memory cells ready to make Ig as soon as antigen enters the system.

The

second time the body is exposed to the same antigen a secondary antibody
response occurs. The secondary antibody response is stronger, quicker, and
mostly consists of IgG immunoglobulins.
Immune competence is dependent on the ability to produce varied types
of antibodies. Immunoglobulin-genes, the Ir region of the B complex, seems to
control the production of IgG. In experiments done by Rees and Nordskog five B
subgroup haplotypes were tested for antibody response.

The groups were

derived from chickens of 10 different inbred lines. The chickens were divided by
their B locus and by their IR-GAT locus which influenced the response to the
amino acid copolymer GAT. The groups were B1B1 Ir-GAT-Lo, B1B1 Ir-GAT-Hi,
B19B19 Ir-GAT-Low B19B19 Ir-GAT-Hi, and B2B2 Ir-Gat intermediate.

The

groups were tested for levels of serum IgG at 3, 6, 9, and 21 weeks of age.
Control of the genetic difference in IgG levels was two-fold greater in birds with
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GAT-Hi regions when compared to birds with GAT-Lo Ir regions. Although the IrGAT region did exert control over the ontogenesis of IgG, most of the genetic
variation was controlled by the B complex haplotype (Rees and Nordskog, 1981).
The most commonly used antigen in the quest to categorize chickens as
either high antibody responders (HA) or low antibody (LA) responders is SRBC
(van der Zijpp et al., 1983). Inoculating chickens with bovine erythrocytes also
stimulates a humoral immune response. BRBC are T-cell-dependent antigens
along with being complex multi-determined antigens (Vainio et al., 1983).
B-Complex Response to BRBC as an Antigen
The levels of primary and secondary immune response differ in.
accordance with B complex haplotypes (van der Zijpp, 1983; van der Zijpp et al.,
1983; van der Zijpp et al., 1982).

Antibody selection and MHC type both

influence chicken response to Marek’s disease (Pinard et al., 1993). Studies that
use erythrocytes (sheep red blood cells SRBC or BRBC) have been essential in
the establishment of the B-complex’s role in antibody response. Primary and
secondary antibody response to SRBC can be quantified through antibody titers.
Siegel and Gross used SRBC as the antigen when divergently selecting for high
and low antibody titers (Siegel and Gross, 1980), among Cornell randombred
populations of chickens (Siegel and Gross, 1980).

The HA line of chickens

exhibited stronger antibody response to Newcastle disease, Mycoplasma
gallisepticum, Eimeria necatrix, and feather mites than did the LA producing
lines. The LA producing lines had a higher antibody response to Escherichia coli
and Staphylococcus aureus (Gross et al., 1980). The studies by Siegel and
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Gross demonstrate immunological differences between lines of chickens
selected for HA and LA response to SRBC (Siegel and Gross, 1980; van der
Zijpp, 1983; van der Zijpp et al., 1983; van der Zijpp et al., 1982)
Dunnington and associates (1984) used lines selected for high and low
antibody titers through ten generations. The only antigen used for selection was
SRBC. By the ninth and tenth generations 99.9% of the LA producing group was
of the genotype B13B13. The HA line had gene frequencies of 5,25, and 80% for
B31, B13, and B21 respectively (Dunnington et al., 1984). The HA and LA lines
were then backcrossed to segregate the B21 and B13 within the HA or LA line.
Although antibody titers produced to SRBC were lower in LA than in HA there
appeared to be significant interactions between background genome and the B
haplotype. Chickens of genotype B13/B21 in the low line had significantly lower
antibody response of B13/B21 chickens of the high line. Interactions between
the MHC haplotype and the background genome appear to have an effect on
antibody response to SRBC (Dunnington etal., 1996).
Differences in antibody titers against SRBC are attributed to different MHC
haplotypes. Groups of birds that serologically resembled B13B13 and B14B14
along with B15B15 were tested for IgG and IgM response to SRBC. The B15B15
chickens had significantly lower IgG and IgM antibody titers in the primary and
secondary response than the B13B13-like and B14B14-like chickens. When the
heterozygous haplotypes (B13B15 and B14B15) were examined they both
produced more anti-SRBC than did the B15B15 haplotypes (Loudovaris et al.,
1990).
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Rous Sarcoma B-Complex (RSV) Effects on Tumor Growth
RSV is an antigen that elicits an immune response through the
endogenous pathway. Antigenic peptide, processed by MHC class I molecules,
is presented to cytotoxic T lymphocytes on the surface of infected cells. The B
complex haplotype plays an important role in the outcome, progression or
regression, or sarcomas formed by RSV (Collins, 1977; Collins and Zsigray,
1984; Hala etal., 1979; Schierman and Collins, 1987; Schierman etal., 1977).
In 1966, Peyton Rous won the Nobel Prize for his work in establishing a
relationship between viruses and cancer. Rous first described this relationship
while studying the sarcoma tumor (a tumor of connective tissue). By injecting
cell-free tumor extracts into healthy chickens Rous found that the healthy
chickens would develop sarcomas. These observations led Rous to propose
that an independent agent, later determined to be a virus, was responsible for the
transmission of the disease (Rous, 1911). This virus was later named Rous
sarcoma virus (RSV) in his honor.
RSV is composed of four genes: gag gene, pol gene, v-src gene, and env.
Overall the responsibility of these four genes is as follows: Gag is responsible for
encoding capsid proteins, pol produces reverse transcriptase, env gene
generates the viral envelope protein, and v-src is responsible for transforming
cells to the malignant phenotype (Plachy and Hejnar, 2002; Svoboda, 1986).
Tumors produced by RSV are sarcomas, also known as tumors of connective
tissue.

.
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RSV is a transforming avian retrovirus. The retrovirus portion implies that
RSV utilizes the enzyme reverse transcriptase to convert the RNA genome into a
single-stranded DNA molecule. The virus then uses this single stranded DNA
molecule as a template to synthesize a double stranded DNA molecule.

By

doing this the virus can incorporate portions of its own DNA into the cell’s DNA,
creating a provirus. Later the DNA is transcribed into RNA and then translated
into viral proteins (Klug et al., 2006). RSV is also an acute transforming virus
meaning that it carries oncogenes. During infection the viral oncogenes (v-onc)
are incorporated into the host’s genome. Once the v-onc is incorporated into the
host genome it is known as c-onc. V-onc genes are able to convert a host cell
into a tumor cell. In the chicken the one gene is known as the sre gene. The vsre gene encodes a tyrosine kinase that is incorporated into the normal c-src. In
a healthy chicken the c-src gene promotes normal cell division. RSV infects cells
that possess the c-src gene. When v-src DNA is incorporated into the c-src
region the normal mechanisms that switch off c-src genes at appropriate times
are no longer able to do so causing uncontrolled cell division (Klug et al., 2006).
The v-src gene transforms normal cells into sarcoma cells which produce viral
peptides (Kaufman and Venugopal, 1998; Plachy etal., 1992).
B-Complex Control in RSV
Resistance to RSV disease susceptibility is dependent on class I molecule
expression.

MHC haplotypes that demonstrate great class I expression

(Kaufman e ta l., 1999b), for example B2B2 genotypes, are superior in their
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resistance ability to RSV than B5B5 when inoculated with RSV in the web wing
(Collins et al., 1978; Taylor et al., 1992b).
Tumors induced by RSV can be either progressive, meaning that they
increase in size over time eventually causing mortality, or regressive, meaning
that the tumors decrease in size over time (Collins and Zsigray, 1984). In 1948,
it was suggested that tumor progression (TPr) and tumor regression (TR) to RSV
were under genetic control of the B complex (Greenwood et al., 1948). In studies
done by Gyles et al., (1971) chickens found to show TPr (a line of White Leghorn
(WL) or TR response (three groups of chickens consisting of a cross of WL and
Giant Jungle Fowl (GJF), WL, and GJF) demonstrated that TPr or TR was a
separate genetic effect than that of malignant transformation by RSV (Gyles and
Brown, 1971). Gyles and Brown (1971) established two lines of chickens, one
TR and the other TPr. By crossing WL with GJF for the F1 generation. In the Fi
generation of the (WL X GJF), 38% regression was seen. There were also Fi
and F2 crosses between (WL X GJF) and pure WL.

When selected for

regression over six generations, TR grew from 18.2% to 63.7% demonstrating
that TR of RSV tumors was a selectable genetic trait (Gyles and Brown, 1971).
In congenic studies by Plachy (1984), congenic lines CB (B12B12) and
CC (B4B4) differing only at the MHC were used. Backcrossed heterozygous Fi
progeny demonstrated that tumor regression to RSV was a dominantly inherited
trait from B12. The congenic lines were also backcrossed with lines CB.I (B7B7)
and IA (B7B7) in the following backcrosses: backcross A ([CB.I x CC] x CC) and
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backcross B ([CC x IA] x IA).

Backcross A had tumor progression whereas

backcross B had tumor regression to sarcomas (Plachy, 1984).
The noninbred line UNH 105 chickens was used when examining B
haplotype association with RSV-induced sarcomas has been investigated.

A

tumor profile index (TPI) was used to quantify tumor growth over time in these
studies. TPI scores range from 1, meaning observed tumor regression within 70
days post inoculation of RSV, through 5, which is characterized as terminal tumor
progression in less than 28 days post inoculation (Collins et al., 1985a). UNH
105 chickens were tested for sarcoma growth after wing inoculation of Bryan high
titer RSV subgroup A (BH RSV (RAV-1) at six weeks o f age.

Tumor

development was observed for 10 weeks and then the experiment was stopped.
Several studies measured sarcoma growth in inoculated chickens with UNH line
105.

The B alleles (B22, B23, B24, B26, and B30) examined for TPI after

inoculation with RSV were studied. B23 was examined in its homozygous and
heterozygous forms as B23B26, B23B24, B23B23, B23B30 and was found to
have an overall regressive effect on sarcomas. B26 was examined in B26B26
B24B26, B22B26, and B22B26 combinations and was found to have an overall
intermediate effect on sarcomas. B24 was examined in B24B24, B24B26, and
B22B24 combinations and was found to have an overall progressive effect on
sarcomas.

B22 was examined in B22B22, B22B30, B22B24, and B22B26

combinations and was found to have an overall intermediate effect on sarcomas.
B30 was examined in B30B30, B26B30, B22B30, and B23B30, combinations
and was found to have an overall progressive effect on sarcomas (Collins et al.,
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1985b, Brown et al., 1982, Taylor et al., 1988, Brown etal., 1982, Lukacs etal.,
\

1989).
The B23 allele appears to have dominance over other alleles in the
heterozygous form (Taylor et al., 1988).
regressor

was

crossed

with

B24B24

In further investigations, B23B23
progressor to

produce

B23B24

heterozygotes. These three haplotypes were used to examine dose effect of
RSV on sarcoma outcome. Two hundred, and 50 pock forming units (pfu) of
RSV were subcutaneously injected into the wing-web of each group of chickens
except for a control group which did not get the injection.

B23 showed

dominance in regression. The homozygous B23B23 and heterozygous B23B24
regressed tumors, while the B24B24 varied tumor growth dependent on viral
dosage (Vincent and Taylor, 1988).
Genes associated with control of sarcoma growth due to RSV lie within
the B-F/B-L region of the MHC B-complex. These genes appear to be linked to,
but not within the B-G region of the complex (Collins et al., 1980). In the study of
several B complex recombinants, with identical B-G haplotypes, TPIs did not
differ significantly from one another unless the B-F/B-L differed (Aeed et al.,
1993).
In recombinant studies, four different MHC recombinant haplotypes, BR1
(F24-G23), BR4 (F2-B23), and BR6 (F21-G23), used three different MHC
haplotypes B19, B23, and B26 as background DNA to study the effects of the BF
region.

BR6 had the lowest TPI on the B26 background while BR4 had the

lowest TPI on the B23 background (Aeed et al., 1993). When compairing BR1,
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BR2 (F2-G23), and BR3 (F2-G23) recombinants in heterozygous combinations
with B2, B5, B23, and B24 ail of the recombinants had varying F-regions and the
same G23 G-regions.

Control over RSV was exerted by the heterozygous

recombinants even though their BG regions were the same, concluding that RSV
regression is dependent on the BF/BL region of the haplotype not the BG region
(Auclair etal., 1995).
In contradiction to the above study by Auclair and colleagues, White and
coworkers (White et al., 1994) found tumor growth in BR2 chickens to be
significantly lower than in BR3 and BR4 birds. These results were unexpected
because all groups possess B-F2 and B-G23 haplotypes.

These different

outcomes might indicate that crossing over between the B-F and B-G regions
occurred at a different point in the BR2 chickens, such that these birds might
have retained genes from the B-F2 haplotype affecting tumor growth (White et
al., 1994).
In order for RSV to infect the cell it must gain access into the cell through
a receptor on the cell specific for the particular subgroup of the virus present.
For the chicken inheritance of this receptor is dominant (Collins and Zsigray,
1984). Sometimes, MHC progression or regression of sarcomas is dependent on
the subgroup of RSV used for inoculation (McBride et al., 1981). If a chicken is
homozygous for cellular resistance to a particular subgroup, then that viral
subgroup will be unable to infect the chicken cell (Svoboda, 1986).
The MHC class I molecule’s ability to bind to RSV peptides determines if a
chicken will be resistant or susceptible to tumors caused by RSV (Kaufman and
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Venugopal, 1998). Chickens resistant to RSV induced tumor have class I MHC
molecules that appropriately bind to RSV peptide bringing it to the surface of the
tumor cell and presenting it for recognition to the CD8+ receptor of a cytotoxic Tcell. Chickens with MHC class I molecules that do not effectively bind to the
peptide are susceptible to RSV induced tumor formation (Kaufman and
Venugopal, 1998; Schierman and Collins, 1987).
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CHAPTER II

B COMPLEX RECOMBINANT EFFECTS ON ROUS SARCOMA TUMOR
OUTCOME AND ANTIBODY RESPONSE AGAINST BOVINE RED BLOOD
CELLS

Introduction
Recognition and elimination of foreign antigen from the body is the key to
the survival of any organism. The system responsible for the elimination and
prevention of antigen invasion is the immune system.

The activation of an

immune response to antigen is dependent on recognition of that antigen as
foreign and the activation of T-cells. The MHC class I and class II molecules are
responsible for the recognition of foreign antigen and activation of T-cells.
MHC class I molecules are on the surface of all nucleated cells. When an
endogenous antigen enters a cell MHC class I molecules recognize, bind to, and
bring to the cell surface, antigenic peptide. The MHC class l:antigen complex
presents itself to CD8+ (killer T-cells). Once stimulated, killer T-cells destroy the
infected cell by attaching porferin proteins to the infected cell membrane. The
porferin proteins form holes in the cell membrane, which cause the cell to lyse.
Activated T-cells also produce granzyme B, an enzyme that causes an enzymatic
chain reaction which leads to apoptosis of the infected cell.
Rous sarcoma virus is an example of an endogenous antigen. Immune
response to RSV is dependent on MHC class I molecules. B complex haplotype
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plays an important role in the progression or regression of sarcomas caused by
RSV (Collins, 1977; Collins and Zsigray, 1984; Plachy et al., 1979; Schierman
and Collins, 1987).
MHC class I molecules are on the surface of antigen presenting cells
(APC) and serve as communication boards to CD4+ T-cells.

APC, like

macrophages, ingest exogenous antigens often through phagocytosis. Inside of
the macrophage the phagosome fuses with the macrophages own endosome
forming the phagoendosome. Enzymes from the phagosome break down the
exogenous antigen. MHC class II molecules are present within the endosome,
and peptide fragments from enzymatic degradation are loaded into the class II
molecule and brought to the surface of the APC. The class II molecule:antigen
complex, at the surface of the APC, binds to the CD4+ receptor of helper T-cells.
When stimulated, activated helper T-cells will bind to B-cells whose B-Cell
Receptor (BCR) is bound to antigenic pathogen. This two step signaling process
activates the B-cell to start producing Ig.

Primary and secondary antibody

response varies with B complex haplotype (Siegel and Gross, 1980; Van Der
Zijpp and Leenstra, 1980)
When injected into a chicken BRBC is a T-cell dependent exogenous
antigen. An immune reaction to BRBC is MHC class II molecule dependent
(Vainio et al., 1984).

When first injected with an antigen a primary immune

antibody response will occur.

The primary immune response is mostly

comprised of IgM. After a primary immune response some of the B-cells reacting
to antigen become memory B-cells.

Memory B-cells are able to produce
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Immunoglobulin G (IgG), also known as IgY for the chicken, quickly in the event
of a second encounter with the same antigen. Upon second introduction of the
antigen the secondary Immunoglobulin response should be quicker and mostly
comprised of IgG immunoglobulins.
Secondary antibody response is mostly comprised of antibody subclass
IgG.

Individually IgG subgroups can be measured through mercaptoethanol

(ME)-resistance. Mercaptoethanol breaks the disulfide bonds and depolymerizes
IgM antibody.

Depolymerized IgM does not contribute to agglutination.

Therefore, antibodies (IgG) resistant to this depolymerization will be measured in
the agglutination reaction (Deutsch and Morton, 1957).
The B complex genes that code for MHC class I, class II, and class IV
molecules are known as BF, BL, and BG genes respectively (Nordskog et al.,
1987; Pink et al., 1977).

Approximately 1 in 2000 experimental matings in

chickens produces a MHC recombinant (Hala et al., 1979; Koch et al., 1977).
The BF/BL region at 92kb in length is comprised of 19 genes (Kaufman et al.,
1999a). This region is compact with BF and BL genes close together; therefore,
recombination between BF and BL is extremely infrequent (Skjodt etal., 1985).
This overall study has two objectives. The first objective is to examine
segregating haplotype combinations of a new major histocompatibility (B)
complex recombinant R13 (BF17-BG23) and B17 for antibody production to
BRBC. The second objective is to evaluate the growth of Rous sarcoma virusinduced tumors for five (B) complex recombinants including the new R13 type.
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The MHC influence on immune response inspired these experiments after a new
MHC recombinant was discovered.
Materials and Methods
Stock
Congenic lines containing six different major histocompatibility (B)
complex recombinants were developed at the University of New Hampshire. The
recombinants and their corresponding B types are described in Table 1. Each
recombinant originated from a separate recombinational event despite some
serological identity among recombinants.

Sires with the desired B complex

recombinant (R1-R6) were crossed with dams of the highly inbred white Leghorn
Line UCD 003 (B17B17).

Ten backcross generations were conducted by

crossing recombinant heterozygous males (RB17) to UCD 003 (B17B17)
females.

After the tenth backcross generation, heterozygotes for each

recombinant were mated inter se to produce six different congenic chicken lines
with 99.9% of their background genome from Line UCD 003 and an individual B
recombinant haplotype.
A new recombinant B haplotype, designated R13 (BF17-BG23), was
found in the tenth backcross generation for R1 (BF21-BG23). Since the R13
recombinant was discovered in a single sire, one additional backcross was made
to the highly inbred white Leghorn Line UCD 003 (B17B17) to increase the R13
population. Heterozygous R13B17 were mated to produce the R13R13 congenic
chickens.
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Experiment one used a single R13B17 male which was mated to five
R13B17 dams to produce the experimental progeny consisting of R13R13,
R13B17, and B17B17 genotypes. These respective genotypes from this mating
segregate in a 1:2:1 ratio. Furthermore, these genotypes would be congenic to
each other as R13 arose in the 10th backcross generation. Experiment two used
five lines congenic for major histocompatibility (B) complex recombinants (R1,
R2, R4, R5, R13) [Table 1].
Haplotype identification
The B haplotypes of all individuals in the backross and experimental
chickens were confirmed through hemagglutination assays using antisera
specific for parental B haplotypes (Briles and Briles, 1982; LePage et al., 2000).
Five hundred micro liters of blood was collected from each bird and placed into
68 pM sodium citrate/ 72 pM sodium chloride anticoagulant solution. Samples
were shipped on ice, overnight to Northern Illinois University.

Fifty pL of 2%

washed erythrocyte 98% saline solution was added to 100 pL of the B haplotype
specific antisera of interest in 10 x 77 mm tubes.

These solutions were

incubated at room temperature for 2 hrs, and then overnight at 3° C while in the
10 x 77 mm tubes.

Solutions were then resuspended, incubated at room

temperature for 1 hr, and read for agglutination.
B haplotypes were also identified through Polymerase Chain Reaction
(PCR) using the procedures of (Fulton et al., 2006). LEI0258 is a microsatellite
marker that maps to chromosome 16 and is physically located within the B
corfiplex, between the BG and BF regions (McConnell et al., 1999). DNA was
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obtained from chicken red blood cells. PCR products are run on a 3% agarose
gel electrophoresis. Attachment of primers to the marker LEI0258 produces a
unique PCR product for each genotype. DNA from the chickens used in these
experiments was amplified

by PCR using the 22

(CACGCAGCAGAACTTGGTAAGG)

and

22

base pair forward

base

pair

reverse

(AGCTGTGCTCAGTCCTCAGTGC ) primers surrounding the LEI0258 marker.
Experimental and production chickens were produced from eggs
^

incubated and hatched at the University of New Hampshire Poultry Research
Farm.

Chicks were vaccinated for Marek’s disease and wing banded for

identification at the time of hatch.

Vaccination against Newcastle-bronchitis

occurred at 10 days of age. Chicks were housed in heated brooder batteries for
six weeks followed by transfer to grower cages. Antibiotic-free food and water
were provided for ad libitum consumption.
Experiment 1: Antigen Inoculation
Bovine red blood cells (BRBC), a T cell-dependent antigen (McArthur et
al., 1973), were collected in Alsever’s solution. The BRBC were washed three
times in a 0.9% sterile NaCI solution. The BRBC were then diluted to a 2.5%
(vol/vol) solution in 0.9% sterile NaCI. A total of 117 progeny from the mating of
R13B17 heterozygous parents were hatched. At 4 weeks of age blood samples
were taken from each chick examined before intravenous injection with BRBC
solution, to determine if any cross-reacting antibody preexisted. Chicks received
wing-web intravenous injections with 1 mL of 2.5% washed BRBC solution.
Blood was collected 7 days after antigen injection for primary antibody response
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measurements. Serum from this blood was recovered after blood clotting and
centrifugation. The serum was stored at -20° C. Chicks were injected a second
time with the BRBC 2.5% solution at 11 weeks for secondary antibody response
measurements.
Antibody Titration
Complement protein in the serum was inactivated by incubation at 56° C
for 1.0 hr.

Primary and secondary antibody responses against BRBC were

measured in serum samples taken 7 days post antigen inoculation at 4 and 11
weeks. Total antibody measurements used the established microtiter procedure
of Wegman and Smithies (1966). Mercaptoethanol (ME)-resistant antibody (IgG)
against BRBC was evaluated using the procedure of (Yamamoto and Glick,
1982). Titers were expressed as log2 of the reciprocal of the highest dilution
exhibiting visible agglutination.
Experiment 2: RSV Challenge and Tumor Scoring
A total 70 chicks of the five congenic lines differing only by their
recombinant B complexes were produced in two hatches.

Each line was

represented by 10 to 15 individuals. At six weeks of age, the chicks received
wing-web intravenous injections with 20 pock forming units of Rous sarcoma
virus (subgroup C).
I

Tumor size was scored at weeks 2, 3, 4, 6, 8, and 10 weeks, post
inoculation in accordance with the guidelines established by (Collins et a i,
1985b). Scores for tumors range on a scale using the values 0= no palpable

65

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

tumor; 1= small tumor up to 0.5 cm diameter; 2= tumor > 0.5 up to 1.2 cm
diameter; 3= tumor>1.2 up to 1/2 wing-web area; 4= tumor> 1/2 wing-web area,
but < entire wing web; 5= tumor filling the entire wing-web; 6= massive tumor
extended beyond wing-web; and 7= death during the 70 day experiment [Table
2]. A tumor profile index (TPI) was assigned to each chicken from the six tumor
size scores using the scale of Collins et ai, (1985a) where 1 = complete
regression by 70 days or a decreasing slope or complete regression by 56 days
followed by recurrence; 2 = general upward trend, a plateau or slight regression
after 56 days; 3 = terminal tumor after 42 days postinoculation; 4 = terminal
tumor between 29 and 42 days postinoculation; and 5 = terminal tumor by 28
days postinoculation [Table 3].
Statistical Analysis
Antibody titers for primary and secondary antibody responses, anti-BRBC
and ME-resistant antibody response were analyzed by least squares ANOVA.
Hatch and B genotype were used as the main effects for ANOVA analysis.
Fisher’s protected LSD at P<0.05 was used to separate significant means.
Data collected from the RSV portion of this study was examined for the
effects of B recombinant genotype on tumor outcome. Hatch and recombinant
haplotype were used as the main effects in repeated measures ANOVA analysis
for tumor growth. Rank transformation was used to evaluate TPI values, which
were then analyzed by ANOVA (Conover and Iman, 1981). Fisher’s protected
LSD was used to determine differences between recombinant groups.
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Recombinant
Designation

International
Designation

BF/BL

BG

R1

B24r1

24

23

R2

B2r1

2

23

R4

B2r3

2

23

R5

B21r1

21

19

R13

B17r1

17

23

Table 1. Table o f Recombinant Groups. The recombinant designation for
each group is the nomenclature used in this study. International designation
represents the BF/BL recombinant haplotype source and when the recombinant
haplotype was described (r1=1st). Recombinants that have the same BF/BL and
BG haplotypes are considered different when they occur from different
recombinant events.
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Score

Description o f tum or

0

No palpable tumor

1

Small tumor <0.5 cm diameter

2

Tumor is >0.5 but less than 1.2 cm diameter

3

Tumor is >1.2 cm but less than 50% of the wingweb area

4

Tumor is >50% of the wingweb area but less than the entire wing web
area

5

Tumor fills the entire wing web area

6

Tumor extends beyond the area of the wingweb

7

Death occurs during the experiment

Table 2. Tumor Score Values. Tumor scoring values were used in accordance
with the system developed by (Collins, 1977). Tumors acquired due to RSV
inoculation in the wingweb of the chicken were given values, as shown above,
depending on their size on weeks 2, 3, 4, 6, 8, and 10 post inoculation.
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TPI Value

Description

1

complete regression by 70 days or a decreasing slope or complete
regression by 56 days followed by recurrence

2

general upward trend, a plateau or slight regression after 56 days

3

terminal tumor after 42 days postinoculation

4

terminal tumor between 29 and 42 days postinoculation

5

terminal tumor by 28 days postinoculation

Table 3. Tumor Profile Index (TPI). The TPI is determined by the progress of
tumor growth for an individual bird. The TPI values of this table are in
accordance with the standard developed by (Collins et al.t 1985a).
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Results
Experiment 1: B Complex Recombinant Anti-BRBC Immune Response
Chicks, congenic at their MHC, having genotypes R13/B17, R13R13, and
B17B17 were hatched and injected with 1mL of 2.5% BRBC at four weeks of age
to induce a primary antibody response.

Blood samples were taken from the

chicks seven days post-injection for primary immune response antibody
evaluation. Total and mercaptoethanol (ME)-resistant (IgG) antibodies against
BRBC were measured using microtiter methods. Total primary antibody titers
were calculated using log2 of the different B haplotypes. All calculations were
held to a p<0.05 for level of significance.

Total primary antibody titers were

significantly higher in both B17B17 and R13B17 compared with R13R13 (Figure
2).
IgG is a subgroup of the total primary antibody response to BRBC. IgG
was measured through mercaptoethanol (ME)-resistance. (ME)-resistant (IgG)
primary antibody titers were calculated using log2 of the different B haplotypes.
(ME)-resistant (IgG) antibody titers differed significantly between R13/B17 and
R13R13, between R13R13 and B17B17, but not between R13B17 and
B17B17genotypes (Figure 2).
At 11 weeks of age the chicks were injected again with 1mL of 2.5%
BRBC to evoke a secondary immune response. Blood samples were taken from
the chicks seven days post-injection for total secondary and (ME) resistant
antibody response evaluation. The total secondary antibody titer of genotype
R13B17 was significantly higher than the titer of R13R13 but not B17B17. For
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total secondary antibody titer B17B17 did not differ significantly from R13R13
(Figure 3).

(ME)-resistant antibody (IgG) titer of genotype R13B17 was

significantly higher than the titer of R13R13 but not B17B17. B17B17 did not
differ significantly from R13R13 for Me-resistant (IgG) titer (Figure 3).
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Figure 2. Prim ary Antibody Response. Mean (+/-SEM) Antibody for R13,
R13B17, and B17 genotypes inoculated with 2.5% BRBC solution. Bars having
no letter in common are significantly different (p<0.05).
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Figure 3. Secondary Antibody Response. Mean (+/-SEM) Antibody for R13,
R13B17, and B17 genotypes inoculated with 2.5% BRBC solution. Bars having
no letter in common are significantly different (p<0.05).
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Experiment 2: B-Complex Recombinant Effects on Rous Sarcoma Tumor
Outcome
Recombinant congenic lines, R1R1, R2R2, R4R4, R5R5, and R13R13,
were injected with 20 pock forming units (pfu) of Bryan high titer strain RSV at six
weeks of age.

TPI and Tumor growth score were in accordance with the

standard set up by Collins et al., (1985a).

Between weeks four and six tumor

growth scores diverged between the recombinant lines (see Figure 4).

The

greatest difference in mean tumor growth score was seen between the R5
recombinant MHC haplotype and the other congenic recombinant lines.

The

mean tumor size for R2 increased sharply from 0-4 weeks, at 4 weeks mean
score was approximately 6 (6=massive tumor extending beyond the wingweb).
From weeks 4-6 mean size score decreased to approximately 5 (5= tumor
formed that filled the entire wingweb). A gradual increase was seen between
weeks 6-10 and then an apparent plateau from weeks 8-10 leveling off
somewhere between 5 and 6 for tumor score size for R2. R4 increased for mean
tumor size score similarly to R2 from weeks 2-4 but then plateaued from weeks
4-10 at approximately the same size score as R2.

R13 increased for mean

tumor score size dramatically from weeks 2-6 and then plateaued for weeks 6-10
just above R2 between tumor score size 5 and 6. R1 increased mean tumor
score size less dramatically than R2, R13, or R4, but was consistent, never
decreasing mean tumor score size over the 10 weeks, and ended with the
highest mean tumor size score at just above 6 (6=massive tumor extending
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beyond the wingweb. The mean tumor size for the R5 line at week 10 was lower
than the mean tumor size for R5 at week 4. By the end of the 10 week period
R1, R2, R4, and R13, all had Tumor score sizes over 5, indicating that the tumor
formed filled at least the entire wingweb area. The Tumor score size for R5 was
significantly lower, approximately 2, indicating that the average tumor size among
the R5 chickens was greater than 0.5 cm by less than 1.2cm in diameter.
For TPI (see Figure 5) R1 line did not show significant difference (p<0.05)
for mean TPI from any of the other congenic recombinant lines tested. Mean TPI
for R1 was approximately 3 (3=terminal tumor after 42 days post inoculation).
TPI for R2 and R4 were significantly different from that of R5 but not from each
other, R1, or R13.

R2 and R4 had similar mean TPI at approximately 4

(4=terminal tumor between 29 and 42 days postinoculation). R13 had a mean
TPI between 3 and 4. TPI for R13 was significantly different from mean TPI for
R5, but not for any other group tested. Mean TPI for R5 was approximately 2
(2=genral upward trend, pleateau, or slight regression after 56 days). Mean TPI
for R5 was significantly different from those of R2, R4, and R13, but not
significantly different from the mean TPI of R1.
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Figure 4. RSV-c Tumor Growth Score fo r R1R1, R2R2, R4R4, R5R5, and
R13R13 Congenic Lines. Mean (+/-SE) Tumor size are for five MHC
recombinant lines over a period of 10 weeks after a 20pfu injection of RSV
subgroup C at six weeks of age. Lines represent tumor growth over time.
Significant differences (p<0.05) were found between recombinant iines see
Figure 5.
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□

R1R1

R4R4

R13R13

Figure 5. Tum or Profile Index (TPI) fo r R1R1, R2R2, R4R4, R5R5, and
R13R13 Congenic Lines. Mean (+/-SE) TPI’s for five MHC recombinant lines
over a period of 10 weeks after a 20pfu injection of RSV subgroup C at six weeks
of age. Significant differences (p<0.05) were found between the recombinant
lines are designated with different letters the significant differences shown in
Figure 5 are consistent with Figure 4.

77

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Discussion
B-Complex Segregating Haplotype For R13 Antibody Response Against Bovine
Red Blood Cells (BRBC)
The first objective of the present study was to examine segregating
haplotype combinations of a new major histocompatibility (B) complex
recombinant R13 (BF17-BG23) and B17 for antibody production to BRBC.
R13/B17, R13R13, and B17B17 congenic lines were the segregating genotypes
injected with 2.5% BRBC antigen.

Total and (ME)-resistant primary antibody

response were higher for R13/B17 and B17B17 genotypes than for R13R13
chickens. R13B17 and B17B17 did not differ significantly in primary antibody
responses. For total and (ME)-resistant secondary antibody (IgG) titer genotype
R13B17 had significantly higher titer than R13R13 but not B17B17. Total and
(ME)-resistant secondary antibody titer of B17B17 chickens did not differ
significantly from R13R13 chickens.
The results suggest a relationship between R13 and B17 that increases
immune response over the homozygotes in primary and secondary immune
response.

R13 (BF/BL17-BG23) and B17 both have BF/BL17 region, but

different BG regions. Also, B17 demonstrates a dominant effect compared to
R13. The differences seen between R13 and B17 may be attributed to the BG
genes since BG is the only genetic difference between R13 and B17. However,
recombination may have affected different genes in R13 than in B17 thereby
impacting the immune response.
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The B complex has been found to have an impact on primary and
secondary antibody response to SRBC. Siegel and Gross used SRBC as the
antigen when divergently selecting for high and low antibody titers, among
Cornell randombred populations of chickens (Siegel and Gross, 1980).

The

studies by Siegel and Gross demonstrate immunological, inherited differences
between lines of chickens selected for HA and LA response to SRBC (Siegel
and Gross, 1980; van der Zijpp, 1983; van der Zijpp et al., 1983; van der Zijpp et
a/., 1982)
Dunnington and associates (1984) used lines selected for high and low
antibody titers through ten generations. The only antigen used for selection was
SRBC. By the ninth and tenth generations 99.9% of the LA producing group was
of the genotype B13B13. The HA line had gene frequencies of 5, 25, and 80%
for B31, B13, and B21 respectively (Dunnington et al., 1984). The HA and LA
lines were then backcrossed to segregate the B21 and B13 within the HA or LA
line. Although antibody titers produced to SRBC were lower in LA than in HA,
there appeared to be significant interactions between background genome and
the B haplotype. Chickens of genotype B13/B21 in the low line had significantly
lower antibody response than did B13/B21 chickens of the high line. Interactions
between the MHC haplotype and the background genome appear to have an
effect on antibody response to SRBC (Dunnington etal., 1996).
Dix and Taylor (1996) examined primary antibody response to SRBC in
lines 6.6-2 (B2B2) and 6.15-5 (B2B2), congenic for the MHC (B) complex. The
total anti-SRBC antibody titer for B5B5 chickens was significantly higher than that
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of B2B2 chickens, and no significant difference was seen between the genotypes
with regards to ME sensitivity antibody to SRBC (Dix and Taylor, 1996).
BG molecules are present on immune cells: thrombocytes, peripheral B
and T lymphocytes, bursal B cells and thymocytes, and stromal cells in the
bursa, thymus, and caecal tonsil of the intestine. However, their role in immune
reaction is still unclear (Guillemot and Auffray, 1989; Kline et al., 1991).

BG

molecules have an important role in the selection of B-cells in the chicken bursa
(Hala eta l, 1981; Salomonsen ef al., 1991b). B-cells produce immunoglobulins.
It may be BG’s influence on B-cell selection that accounts for the differences
between the R13 and B17 haplotypes. An entirely novel immune function effect
that can be attributed to BG molecules might possibly account for the differences
seen in the present study.
R4 and R2 both have BF/BL-2 and BG-23 genotypes. However, R4 and
R2 genotypes developed from different recombination events.

The crossover

break points for R2 and R4 occur at different points in the region of the BG1
locus (Miller, 2005). Studies using fully congenic lines R2 and R4 report R2 as
having more resistance to tumors in response to MDV than R4 (Schat et al.,
1994).

While serotyping can indicate the BF/BL and BG haplotypes of a

recombinant

chicken,

it

cannot

identify

the

point

of

recombination.

Recombination events may include or exclude genes important to immune
response. As R13 has evolved from a recombination event making it different
from B17B17, it is possible that points of recombination may involve a gene or
genes that affect antibody response.
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Gene dose has been found to affect phagocytosis of SRBC in aneuploid
chickens (Qureshi et al., 1989). It is possible that BG dose could be affecting
phagocytosis of BRBC which is why there is no difference seen between the
heterozygous R13B17 genotype and the B17 genotype. It is also possible that
the BG17 allele demonstrates dominant expression over the BG23 allele which
would explain the difference seen between the heterozygous R13B17 genotype
and the B17 genotype.
Gehad

and

colleagues (1999)

examined

interleukin-2 (IL-2)

and

lymphocyte proliferation effects of genetic selection and MHC haplotypes on HA
and LA antibody production against SRBC. Chickens used in this experiment
had segregating genotypes for antibody production against SRBC of B31, B13,
and B21. Chickens selected for HA production to SRBC had lower lymphocyte
mitogenic activity while chickens selected for LA production to SRBC had higher
lymphocyte mitogenic activity. Results from this study indicated that humoral and
cell mediated immunity were under different genetic controls (Gehad et al.,
1999).
The function of the BG region of the B complex is still relatively
unexplored. The present study demonstrates the possibility that the BG region
may affect primary and secondary antibody response against BRBC.

Future

studies with congenic lines that isolate the BG region and pinpoint the
recombinant break point of R13 will be beneficial to a greater understanding of
the role BG plays in immunity.
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B-Complex Recombinant Effects on Rous Sarcoma Tumor Outcome
The second objective of the present study was to evaluate the growth of
Rous sarcoma virus- induced tumors for five (B) complex recombinants including
the new R13 type. Recombinant congenic lines, R1R1, R2R2, R4R4, R5R5, and
R13R13, were injected with 20 pock forming units (pfu) of Bryan high titer strain
RSV at six weeks of age. Over the next ten weeks measurements for Tumor
growth scores were taken at 2, 4, 6, 8, and 10 weeks. TPI and Tumor growth
score were assigned in accordance with the standard of Collins and colleagues
(1977).

Only R5R5 regressed Rous sarcomas among the five genotypes

tested.
White and colleagues, (1994) used congenic lines R1R1, R2R2, R4R4,
and R5R5 to examine tumor outcome in response to RSV subgroup A. The
chicken lines that White used were developing congenic lines at the MHC B
complex with a 93% uniformed background DNA coming from matings and
backcrosses with UCD003 B17B17 inbred line.

White reported that R2R2

haplotypes had significantly lower TPIs than R1R1, R4R4, and R5R5 haplotypes
(White et al., 1994). Growth of RSV induced tumors is dependent on the ability
of the v-src oncogen to mediate tumor cell proliferation and by viral replicationspecific genes ability to recruit new tumor cells (Taylor et al., 1992a). White and
colleagues (1994) injected 50pfu of RSV-A into the wingweb of the experimental
chickens.

In the present experiment 20pfu of RSV-C was used for wingweb

injection. MHC progression or regression of sarcomas can be dependent on the
subgroup of RSV used for inoculation (McBride et al., 1981).
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Vincent and Taylor (1988) examined three groups of chickens, B
genotypes:

B23/B23 (tumor regresssor),

B23/B24,

and B24/B24 (tumor

progressor), for sarcoma outcome to three different dilutions (200pfu, 50pfu, and
20pfu) of Bryan high titer RSV (RAV-1). Chickens were examined for TPI, in
accordance with the system set up by Collins and colleagues (1977). The result
of this examination by Vincent and Taylor (1998) revealed an interaction between
B genotype and viral dose that affected sarcoma outcome.

Chickens with B

genotype B24/B24 differed significantly in sarcoma outcome depending on viral
dosage. At a RSV dose of 200pfu B24/B24 chickens had an average TPI of 3.1;
at 50 pfu average TPI was 2.6. For all other B genotype RSV dose combinations
TPI was 1.8 or less, and significant differences were not seen between the viral
doses.

These results demonstrated that viral dose in combination with B

genotype can affect sarcoma outcome (Vincent and Taylor, 1988). Differences in
the RSV dose used for inoculation could account for the differences seen in
comparative groups from the present study and the White study.
Studies by White and colleagues (1994) investigated tumor growth,
stimulated by RSV-A, in homozygous B17 progeny produced by heterozygous
recombinant parents used in the experiment.

Although B haplotype of the

progeny were all homozygous B17 haplotype differences were seen between the
B17 progeny produced by the heterozygous R2B17 parents and the other
homozygous B17 progeny produced by the other heterozygous recombinant
parents. These results suggest that sarcoma outcome for B17 progeny from
homozygous R2 matings, reported by White and colleagues (1994), may be
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attributed to background genes. In the present study congenic lines were 99.9%
similar in background DNA from inbred line UCD003 (B17B17). The differences
in background gene uniformity between White’s recombinant (93% background
gene uniformity) [(White et al., 1994)] and the current experiment (99.9%
background gene uniformity) may account for the differences seen in R2
genotype control of the tumor response.
Aeed and colleagues (1993) used R1, R2, R4, R5 heterozygous matings
with B19 (tumor regressor) [Gebriel and Nordskog, 1983], B23 (tumor regressor)
[Vincent and Taylor, 1988], or B26 chicks. B19, B23, or B26 chicks were from
different genetic backgrounds. Aeed reported that groups of chicks that had the
BF/BL-2 (R2 and R4) had stronger anti-tumor responses against Rous sarcomas
than the BF/BL-24 (R1) haplotypes. Our study using RSV subgroup C concurred
with the findings of R1 but not with those of R2 and R4. Results reported by
White et al., (1994) concurred with our findings with regards to R4’s effect on
Rous sarcoma outcome.

Differences in background gene uniformity may

account for the differences seen between the studies.
Schulten and Taylor (unpublished data) found that fully developed
congenic lines differed in tumor growth caused by RSV subgroup A. R1R1 and
R4R4 genotypes had a higher tumor growth and TPI than did R2R2, R3R3,
R5R5 and R6R6 chickens. Serologically similar recombinants R2, R3, and R4
differed in tumor growth. R5 and R6 did not differ from each other suggesting a
lack of B-6 region effect. The R2, R3, and R4 types have different recombination
points and therefore have different genes that impact tumor growth.
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Differences seen between studies done by White and colleagues and the
present study, with regards to congenic recombinant’s R2 and R4 control of Rous
sarcomas, warrant further investigation.

Additional genes affecting Rous

sarcoma outcome may lie outside of the MHC region and be able to account for
these discrepancies. A greater understanding of BG’s role in immune function
may lead to a better understanding of tumor growth.
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